Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:monofluorobenzenes
go back to main search page
Accession:CHEBI:83575 term browser browse the term
Definition:Any member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying a single fluorine substitutent.


show annotations for term's descendants           Sort by:
 
1-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 increases chemical synthesis
increases abundance
increases glucuronidation
multiple interactions
ISO CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam
CYP3A4 protein results in increased abundance of 1-hydroxymethylmidazolam
CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam
[[3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[5-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[6-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[6-methylflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[7-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[artemetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[beta-Naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[eupatilin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[sinensetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam] which results in increased abundance of 1-hydroxymethylmidazolam glucuronide; [CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased abundance of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [Ketoconazole results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of 1-hydroxymethylmidazolam; [L 754394 results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of 1-hydroxymethylmidazolam; acacetin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Apigenin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 1-hydroxymethylmidazolam]; diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; flavanone promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; flavone promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; galangin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased abundance of 1-hydroxymethylmidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Rifampin promotes the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Troleandomycin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]
CTD PMID:10997946 PMID:12401345 PMID:12695342 PMID:18191104 PMID:20233841 PMID:21053930 PMID:21915887 PMID:23850985 PMID:26958860 PMID:27485346 PMID:30087611 PMID:31756459 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis ISO CYP3A5 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam CTD PMID:18191104 PMID:26958860 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
JBrowse link
G Tspo translocator protein affects binding EXP 1-hydroxymethylmidazolam binds to TSPO protein; 1-hydroxymethylmidazolam metabolite binds to TSPO protein CTD PMID:7603229 NCBI chr 7:124,460,358...124,470,610
Ensembl chr 7:124,460,358...124,470,609
JBrowse link
1-hydroxymidazolam beta-D-glucuronide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions ISO [CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam] which results in increased abundance of 1-hydroxymethylmidazolam glucuronide CTD PMID:27485346 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
4-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 increases chemical synthesis
multiple interactions
ISO CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam
[CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased abundance of 4-hydroxymidazolam; [CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam; acacetin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; Apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 4-hydroxymidazolam]; diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; flavanone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; flavone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; galangin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Troleandomycin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]
CTD PMID:12695342 PMID:18191104 PMID:21053930 PMID:27485346 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis
multiple interactions
ISO CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam
diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]
CTD PMID:18191104 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
JBrowse link
azaperone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Azaperone results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
JBrowse link
bicalutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aamp angio-associated, migratory cell protein increases expression ISO bicalutamide results in increased expression of AAMP mRNA CTD PMID:16631469 NCBI chr 9:81,560,836...81,566,642
Ensembl chr 9:81,560,842...81,566,642
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO bicalutamide results in decreased activity of ABCB11 protein CTD PMID:28437613 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 decreases activity ISO bicalutamide results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Acp3 acid phosphatase 3 decreases expression ISO bicalutamide results in decreased expression of ACP3 mRNA CTD PMID:15638997 NCBI chr 8:112,838,574...112,884,062
Ensembl chr 8:112,834,707...112,884,077
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO bicalutamide results in increased expression of ACSL1 mRNA CTD PMID:15790403 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
JBrowse link
G Adam9 ADAM metallopeptidase domain 9 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] CTD PMID:17342749 NCBI chr16:71,810,377...71,887,926
Ensembl chr16:71,810,377...71,887,926
JBrowse link
G Adrb2 adrenoceptor beta 2 decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of ADRB2 mRNA; bicalutamide results in decreased expression of ADRB2 protein
bicalutamide inhibits the reaction [Triiodothyronine results in increased expression of ADRB2 protein]
CTD PMID:18454446 NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member increases expression ISO bicalutamide results in increased expression of AGR2 mRNA CTD PMID:15638997 NCBI chr 6:55,465,782...55,487,087
Ensembl chr 6:55,465,782...55,487,714
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of AKT1 protein] CTD PMID:17325745 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA] CTD PMID:17526768 NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882
JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 increases expression ISO bicalutamide results in increased expression of ALDH3A2 mRNA CTD PMID:15638997 NCBI chr10:47,525,486...47,546,535
Ensembl chr10:47,525,493...47,546,345
JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO bicalutamide results in decreased expression of AMACR mRNA CTD PMID:15638997 NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326
JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 increases expression ISO bicalutamide results in increased expression of AMD1 mRNA CTD PMID:15790403 NCBI chr20:45,384,000...45,399,694
Ensembl chr20:45,384,000...45,399,694
JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 increases expression ISO bicalutamide results in increased expression of ANKIB1 mRNA CTD PMID:16631469 NCBI chr 4:27,473,477...27,597,206
Ensembl chr 4:27,473,477...27,597,206
JBrowse link
G Ar androgen receptor decreases response to substance
decreases expression
multiple interactions
increases expression
decreases activity
affects binding
affects response to substance
affects localization
ISO
EXP
AR gene mutant form results in decreased susceptibility to bicalutamide; AR protein alternative form results in decreased susceptibility to bicalutamide
bicalutamide results in decreased expression of AR protein
bicalutamide binds to and results in decreased activity of AR protein; bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]]
bicalutamide results in increased localization of and results in increased activity of AR protein
bicalutamide results in increased expression of AR; bicalutamide results in increased expression of AR protein
bicalutamide results in decreased expression of AR; bicalutamide results in decreased expression of AR mRNA
bicalutamide results in decreased activity of AR protein
[bicalutamide binds to AR protein] which binds to KLK3 promoter; bicalutamide binds to AR protein
AR protein affects the susceptibility to bicalutamide
[Azacitidine analog results in increased expression of AR protein] which results in increased susceptibility to bicalutamide; [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; [bicalutamide co-treated with Testosterone] affects the expression of and results in decreased activity of AR protein; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of and affects the localization of AR protein alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR protein; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB protein]; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; [Goserelin co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]]; bicalutamide binds to and affects the localization of and affects the activity of AR protein; bicalutamide binds to and results in decreased activity of AR protein; bicalutamide binds to and results in increased activity of AR protein mutant form; bicalutamide inhibits the reaction [[Dihydrotestosterone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [[Metribolone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [AR protein alternative form binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein alternative form promotes the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; bicalutamide inhibits the reaction [AR protein binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone affects the localization of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of and results in increased phosphorylation of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein]; bicalutamide inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Flutamide results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Metribolone results in increased folding of and results in increased stability of AR protein]; bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein]; bicalutamide inhibits the reaction [Sirolimus results in increased activity of AR protein]; bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]; bicalutamide promotes the reaction [AR protein binds to KLK3 promoter]; bicalutamide promotes the reaction [AR protein binds to NCOR2 protein]; bicalutamide promotes the reaction [Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein alternative form]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein]; methoxyacetic acid inhibits the reaction [bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]]; mibolerone inhibits the reaction [bicalutamide results in increased expression of AR protein]; Resveratrol promotes the reaction [bicalutamide results in decreased activity of AR protein]
bicalutamide affects the localization of AR protein
CTD PMID:10053169 PMID:11751618 PMID:11845989 PMID:11956172 PMID:11981028 PMID:12015321 PMID:12114440 PMID:12376534 PMID:12730620 PMID:12970580 PMID:15171712 PMID:15308689 PMID:15336702 PMID:15638997 PMID:15994348 PMID:16015592 PMID:16266977 PMID:16877366 PMID:17606915 PMID:17723170 PMID:17804755 PMID:18324645 PMID:18324785 PMID:18486176 PMID:18487222 PMID:18776922 PMID:18922931 PMID:19131511 PMID:19359544 PMID:19587329 PMID:20032058 PMID:20729295 PMID:21036700 PMID:21308717 PMID:21506597 PMID:23562765 PMID:23603339 PMID:24323034 PMID:24759320 PMID:25752796 PMID:26867867 PMID:27473015 PMID:27720946 PMID:28500234 PMID:28757136 PMID:29383186 PMID:29427707 PMID:29462692 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arg1 arginase 1 decreases expression ISO bicalutamide results in decreased expression of ARG1 protein CTD PMID:20711410 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
JBrowse link
G Arg2 arginase 2 increases expression ISO bicalutamide results in increased expression of ARG2 protein CTD PMID:20711410 NCBI chr 6:102,311,097...102,338,406
Ensembl chr 6:102,311,116...102,338,520
JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 increases expression ISO bicalutamide results in increased expression of ASAP2 mRNA CTD PMID:16631469 NCBI chr 6:43,231,178...43,348,606
Ensembl chr 6:43,234,526...43,343,551
JBrowse link
G Atf3 activating transcription factor 3 decreases expression
increases expression
ISO bicalutamide results in decreased expression of ATF3 protein
bicalutamide results in increased expression of ATF3 mRNA
CTD PMID:15638997 PMID:16516039 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO bicalutamide results in increased expression of ATP5ME mRNA CTD PMID:16631469 NCBI chr14:2,325,308...2,326,436
Ensembl chr14:2,325,308...2,326,436
JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 increases expression ISO bicalutamide results in increased expression of B4GALT6 mRNA CTD PMID:16631469 NCBI chr18:15,462,913...15,525,584
Ensembl chr18:15,462,913...15,525,579
JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO bicalutamide results in decreased expression of BARD1 mRNA CTD PMID:15638997 NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression
increases expression
multiple interactions
ISO bicalutamide results in decreased expression of BAX
bicalutamide results in increased expression of BAX protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of BAX protein; [Niclosamide co-treated with bicalutamide] results in increased expression of BAX protein; bicalutamide inhibits the reaction [Niclosamide results in decreased expression of BAX protein]
CTD PMID:11845989 PMID:27132804 PMID:28500234 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bche butyrylcholinesterase decreases expression ISO bicalutamide results in decreased expression of BCHE mRNA CTD PMID:15638997 NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions
ISO bicalutamide results in increased expression of BCL2
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein]
CTD PMID:11845989 PMID:28500234 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of BCL2L1 protein
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein]
CTD PMID:28500234 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO bicalutamide results in decreased expression of BIRC5 mRNA CTD PMID:15638997 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression ISO bicalutamide results in increased expression of BNIP3 mRNA CTD PMID:15790403 NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
JBrowse link
G Btbd3 BTB domain containing 3 increases expression ISO bicalutamide results in increased expression of BTBD3 mRNA CTD PMID:16631469 NCBI chr 3:131,330,338...131,360,554
Ensembl chr 3:131,351,587...131,357,929
JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression ISO bicalutamide results in decreased expression of BUB1B mRNA CTD PMID:15638997 NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CASP3 protein; bicalutamide results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:15638997 PMID:27132804 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp7 caspase 7 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form] CTD PMID:28500234 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] CTD PMID:16317058 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccna2 cyclin A2 decreases expression ISO bicalutamide results in decreased expression of CCNA2 mRNA CTD PMID:15887248 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO bicalutamide results in decreased expression of CCNB1 mRNA CTD PMID:15887248 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnb1ip1 cyclin B1 interacting protein 1 increases expression ISO bicalutamide results in increased expression of CCNB1IP1 mRNA CTD PMID:15638997 NCBI chr15:27,720,220...27,736,528
Ensembl chr15:27,720,223...27,733,785
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
ISO Niclosamide promotes the reaction [bicalutamide results in decreased expression of CCND1 protein] CTD PMID:28500234 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccng2 cyclin G2 increases expression ISO bicalutamide results in increased expression of CCNG2 mRNA CTD PMID:15790403 NCBI chr14:16,267,572...16,276,068
Ensembl chr14:16,267,573...16,276,068
JBrowse link
G Ccpg1 cell cycle progression 1 increases expression ISO bicalutamide results in increased expression of CCPG1 mRNA CTD PMID:15638997 NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039
JBrowse link
G Cd40 CD40 molecule multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA]] CTD PMID:16317058 NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
JBrowse link
G Cd9 CD9 molecule increases expression ISO bicalutamide results in increased expression of CD9 mRNA CTD PMID:15790403 NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
JBrowse link
G Cdc20 cell division cycle 20 decreases expression ISO bicalutamide results in decreased expression of CDC20 mRNA CTD PMID:15638997 NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015
JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO bicalutamide results in decreased expression of CDC6 mRNA; bicalutamide results in decreased expression of CDC6 protein CTD PMID:15887248 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
JBrowse link
G Cdh1 cadherin 1 affects localization ISO bicalutamide affects the localization of CDH1 protein CTD PMID:17440980 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression ISO bicalutamide results in decreased expression of CDK1 mRNA CTD PMID:15638997 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
ISO bicalutamide results in increased expression of CDKN1A; bicalutamide results in increased expression of CDKN1A mRNA; bicalutamide results in increased expression of CDKN1A protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CDKN1A protein
CTD PMID:11845989 PMID:15638997 PMID:27132804 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO bicalutamide results in increased expression of CDKN1B CTD PMID:11845989 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO bicalutamide results in decreased expression of CDKN2C mRNA CTD PMID:15638997 NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression ISO bicalutamide results in decreased expression of CKS2 mRNA CTD PMID:15638997 NCBI chr17:13,587,664...13,593,423
Ensembl chr17:13,587,665...13,593,423
JBrowse link
G Clgn calmegin increases expression ISO bicalutamide results in increased expression of CLGN mRNA CTD PMID:15638997 NCBI chr19:24,545,257...24,578,527
Ensembl chr19:24,545,318...24,576,798
JBrowse link
G Clu clusterin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU protein] CTD PMID:17148459 PMID:17325745 NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
JBrowse link
G Copb2 COPI coat complex subunit beta 2 increases expression ISO bicalutamide results in increased expression of COPB2 mRNA CTD PMID:16631469 NCBI chr 8:106,582,339...106,603,763 JBrowse link
G Crebbp CREB binding protein multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in decreased expression of CREBBP protein] CTD PMID:15378487 NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP11A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP11A1 protein] CTD PMID:21273442 NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP19A1 protein] CTD PMID:21273442 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] CTD PMID:23603339 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions EXP bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]] CTD PMID:20032058 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of DEPTOR mRNA] CTD PMID:26558456 NCBI chr 7:94,795,161...95,000,750
Ensembl chr 7:94,795,214...94,995,809
JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO bicalutamide results in increased expression of DIO3 mRNA CTD PMID:15638997 NCBI chr 6:134,627,278...134,629,139
Ensembl chr 6:134,627,278...134,629,138
JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 decreases expression ISO bicalutamide results in decreased expression of DKC1 mRNA CTD PMID:15638997 NCBI chr  X:155,844,914...155,862,363
Ensembl chr  X:155,844,857...155,862,475
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO bicalutamide results in increased expression of DNAJB9 mRNA CTD PMID:15638997 NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
JBrowse link
G Drd4 dopamine receptor D4 decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of DRD4 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]
CTD PMID:19587329 NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483
JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO bicalutamide results in decreased expression of EBP mRNA CTD PMID:15638997 NCBI chr  X:15,049,394...15,055,782
Ensembl chr  X:15,049,462...15,055,781
JBrowse link
G Egf epidermal growth factor multiple interactions ISO bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of EGFR protein] CTD PMID:29383186 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:21036700 NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
JBrowse link
G Eppin epididymal peptidase inhibitor decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of EPPIN mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]
CTD PMID:19587329 NCBI chr 3:161,043,761...161,050,550
Ensembl chr 3:161,041,727...161,050,557
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]] CTD PMID:29383186 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
JBrowse link
G Etl4 enhancer trap locus 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of KIAA1217 mRNA] CTD PMID:17624924 NCBI chr17:87,173,265...87,681,268
Ensembl chr17:87,274,944...87,681,317
JBrowse link
G Etv1 ETS variant transcription factor 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ETV1 mRNA] CTD PMID:28757136 NCBI chr 6:58,467,215...58,558,640
Ensembl chr 6:58,467,254...58,558,631
JBrowse link
G Ezr ezrin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of EZR mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of EZR protein] CTD PMID:16873375 NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein] CTD PMID:18801408 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
JBrowse link
G Fgf13 fibroblast growth factor 13 increases expression ISO bicalutamide results in increased expression of FGF13 mRNA CTD PMID:15638997 NCBI chr  X:142,053,648...142,589,274
Ensembl chr  X:142,053,654...142,248,369
JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression ISO bicalutamide results in increased expression of FKBP11 mRNA CTD PMID:15638997 NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of FKBP5 mRNA
[Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA
CTD PMID:28500234 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FOS mRNA]; bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of RHOX5 protein] CTD PMID:19587329 NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO bicalutamide results in increased expression of GADD45A mRNA CTD PMID:15638997 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Gcg glucagon decreases expression ISO bicalutamide results in decreased expression of GCG mRNA CTD PMID:15638997 NCBI chr 3:48,442,635...48,451,650
Ensembl chr 3:48,442,635...48,451,650
JBrowse link
G Gpc1 glypican 1 decreases expression ISO bicalutamide results in decreased expression of GPC1 mRNA CTD PMID:15638997 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of GPD1 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]
CTD PMID:19587329 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
JBrowse link
G Gpnmb glycoprotein nmb increases expression ISO bicalutamide results in increased expression of GPNMB mRNA CTD PMID:15638997 NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683
JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A decreases expression ISO bicalutamide results in decreased expression of GPRC5A mRNA CTD PMID:15638997 NCBI chr 4:168,832,937...168,851,650
Ensembl chr 4:168,832,910...168,851,652
JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] CTD PMID:16496412 NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819
JBrowse link
G Gtpbp2 GTP binding protein 2 increases expression ISO bicalutamide results in increased expression of GTPBP2 mRNA CTD PMID:15638997 NCBI chr 9:17,198,957...17,208,456
Ensembl chr 9:17,198,957...17,209,220
JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO bicalutamide results in increased expression of HYOU1 mRNA CTD PMID:15638997 NCBI chr 8:48,699,796...48,711,912
Ensembl chr 8:48,699,769...48,711,910
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]] CTD PMID:16317058 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
increases expression
ISO [bicalutamide co-treated with Tamoxifen] results in decreased expression of IGF1 protein; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1 mRNA]
bicalutamide results in increased expression of IGF1 mRNA; bicalutamide results in increased expression of IGF1 protein
CTD PMID:16368782 PMID:16847815 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785
JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions
increases expression
ISO
EXP
bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA]
bicalutamide results in increased expression of IGFBP2 mRNA
CTD PMID:10604720 PMID:16368782 NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression
decreases secretion
decreases expression
ISO
EXP
[bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 mRNA
bicalutamide results in decreased secretion of IGFBP3 protein
bicalutamide results in decreased expression of IGFBP3 mRNA
CTD PMID:10604720 PMID:16368782 PMID:16847815 NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 increases expression EXP bicalutamide results in increased expression of IGFBP4 mRNA CTD PMID:10604720 NCBI chr10:86,950,555...86,962,563
Ensembl chr10:86,950,557...86,962,578
JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 increases expression EXP bicalutamide results in increased expression of IGFBP5 mRNA CTD PMID:10604720 NCBI chr 9:80,154,230...80,166,813
Ensembl chr 9:80,150,211...80,167,033
JBrowse link
G Il6 interleukin 6 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [IL6 protein results in increased expression of KLK3 mRNA] CTD PMID:11410519 PMID:14532843 PMID:16317058 PMID:19240160 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Kif20a kinesin family member 20A decreases expression ISO bicalutamide results in decreased expression of KIF20A mRNA CTD PMID:15638997 NCBI chr18:27,424,328...27,432,814
Ensembl chr18:27,424,328...27,432,814
JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 increases expression ISO bicalutamide results in increased expression of LAMP2 mRNA CTD PMID:16631469 NCBI chr  X:124,722,628...124,766,079
Ensembl chr  X:124,722,628...124,766,044
JBrowse link
G Lamp3 lysosomal-associated membrane protein 3 increases expression ISO bicalutamide results in increased expression of LAMP3 mRNA CTD PMID:15638997 NCBI chr11:84,930,965...85,000,694
Ensembl chr11:84,972,132...85,000,681
JBrowse link
G Lcn2 lipocalin 2 increases expression ISO bicalutamide results in increased expression of LCN2 mRNA CTD PMID:15638997 NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
JBrowse link
G Ldlr low density lipoprotein receptor affects localization ISO bicalutamide affects the localization of LDLR protein CTD PMID:17440980 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G Lmnb1 lamin B1 decreases expression ISO bicalutamide results in decreased expression of LMNB1 mRNA CTD PMID:15638997 NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
JBrowse link
G LOC102549061 histone H2B type 1-N-like increases expression ISO bicalutamide results in increased expression of H2BC3 mRNA CTD PMID:15790403 NCBI chr17:43,627,872...43,628,518
Ensembl chr17:43,627,930...43,628,310
JBrowse link
G Lrba LPS responsive beige-like anchor protein increases expression ISO bicalutamide results in increased expression of LRBA mRNA CTD PMID:15790403 NCBI chr 2:185,590,983...186,110,491
Ensembl chr 2:185,524,774...186,110,495
JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 decreases expression ISO bicalutamide results in decreased expression of MAD2L1 mRNA CTD PMID:15638997 NCBI chr 4:97,530,993...97,543,179
Ensembl chr 4:97,531,083...97,537,086
JBrowse link
G Man1a1 mannosidase, alpha, class 1A, member 1 increases expression ISO bicalutamide results in increased expression of MAN1A1 mRNA CTD PMID:15638997 NCBI chr20:35,257,688...35,450,132
Ensembl chr20:35,257,985...35,450,513
JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein CTD PMID:15466214 NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758
JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein CTD PMID:15466214 NCBI chr 7:11,458,971...11,478,520
Ensembl chr 7:11,458,967...11,478,489
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:15466214 PMID:29383186 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK3 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:15466214 PMID:29383186 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 increases expression ISO bicalutamide results in increased expression of MBD2 mRNA CTD PMID:16631469 NCBI chr18:65,814,026...65,885,115
Ensembl chr18:65,814,026...65,885,114
JBrowse link
G Mcm2 minichromosome maintenance complex component 2 decreases expression ISO bicalutamide results in decreased expression of MCM2 mRNA CTD PMID:15638997 NCBI chr 4:120,825,699...120,840,221
Ensembl chr 4:120,825,699...120,840,111
JBrowse link
G Mdk midkine increases expression ISO bicalutamide results in increased expression of MDK mRNA CTD PMID:15638997 NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] CTD PMID:11139396 PMID:17371283 NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
JBrowse link
G Mir21 microRNA 21 multiple interactions ISO bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] CTD PMID:23052036 PMID:25969534 NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO bicalutamide results in decreased expression of MKI67 mRNA CTD PMID:15638997 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
JBrowse link
G Mme membrane metallo-endopeptidase increases expression ISO bicalutamide results in increased expression of MME mRNA CTD PMID:15790403 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO bicalutamide inhibits the reaction [Androgens results in increased expression of MMP13 mRNA] CTD PMID:15138554 NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of MMP2 mRNA] CTD PMID:16888681 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
decreases expression
ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC mRNA; [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC protein; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC mRNA]; Niclosamide inhibits the reaction [bicalutamide results in increased expression of MYC protein]
bicalutamide results in decreased expression of MYC mRNA
CTD PMID:15638997 PMID:24759320 PMID:28500234 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Myo6 myosin VI increases expression ISO bicalutamide results in increased expression of MYO6 mRNA CTD PMID:15790403 PMID:16631469 NCBI chr 8:87,583,649...87,731,271
Ensembl chr 8:87,630,916...87,731,269
JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein] CTD PMID:11981028 NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide CTD PMID:19240160 NCBI chr 5:5,466,544...5,696,540
Ensembl chr 5:5,616,483...5,694,598
JBrowse link
G Ncor2 nuclear receptor co-repressor 2 multiple interactions ISO bicalutamide promotes the reaction [AR protein binds to NCOR2 protein] CTD PMID:11981028 NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
JBrowse link
G Nebl nebulette increases expression ISO bicalutamide results in increased expression of NEBL mRNA CTD PMID:15638997 NCBI chr17:84,141,014...84,247,038
Ensembl chr17:84,140,489...84,488,601
JBrowse link
G Nek2 NIMA-related kinase 2 decreases expression ISO bicalutamide results in decreased expression of NEK2 mRNA CTD PMID:15638997 NCBI chr13:110,511,546...110,524,750
Ensembl chr13:110,511,668...110,522,769
JBrowse link
G Niban1 niban apoptosis regulator 1 increases expression ISO bicalutamide results in increased expression of NIBAN1 mRNA CTD PMID:15638997 NCBI chr13:68,949,665...69,101,600
Ensembl chr13:68,949,665...69,101,588
JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions
decreases expression
ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA; bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]
bicalutamide results in decreased expression of NKX3-1 mRNA
CTD PMID:11751618 PMID:15638997 PMID:28500234 PMID:29462692 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421
JBrowse link
G Nrp1 neuropilin 1 decreases expression ISO bicalutamide results in decreased expression of NRP1 mRNA CTD PMID:15638997 NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858
JBrowse link
G Nts neurotensin decreases response to substance ISO NTS protein results in decreased susceptibility to bicalutamide CTD PMID:17044078 NCBI chr 7:44,111,594...44,120,998
Ensembl chr 7:44,111,151...44,121,130
JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 decreases expression ISO bicalutamide results in decreased expression of NUSAP1 mRNA CTD PMID:15638997 NCBI chr 3:111,422,267...111,452,600
Ensembl chr 3:111,422,267...111,452,971
JBrowse link
G Osm oncostatin M multiple interactions ISO bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein] CTD PMID:12114440 NCBI chr14:84,457,487...84,469,426
Ensembl chr14:84,465,515...84,470,409
JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions
increases response to substance
ISO bicalutamide promotes the reaction [PA2G4 protein binds to KLK3 promoter]
PA2G4 protein results in increased susceptibility to bicalutamide
CTD PMID:15994225 NCBI chr 7:2,979,587...2,987,055
Ensembl chr 7:2,979,588...2,987,055
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of PARP1 protein modified form] CTD PMID:28500234 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Pbk PDZ binding kinase decreases expression ISO bicalutamide results in decreased expression of PBK mRNA CTD PMID:15638997 NCBI chr15:42,489,253...42,500,377
Ensembl chr15:42,489,377...42,500,395
JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO bicalutamide results in decreased expression of PCNA mRNA CTD PMID:15638997 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
JBrowse link
G Pds5b PDS5 cohesin associated factor B multiple interactions ISO bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN] CTD PMID:15754350 NCBI chr12:659,995...794,042
Ensembl chr12:660,011...794,042
JBrowse link
G Pecr peroxisomal trans-2-enoyl-CoA reductase increases expression ISO bicalutamide results in increased expression of PECR mRNA CTD PMID:15638997 NCBI chr 9:79,601,937...79,630,547
Ensembl chr 9:79,601,901...79,630,536
JBrowse link
G Pgr progesterone receptor multiple interactions ISO bicalutamide binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Phb prohibitin multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB protein]; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [PHB protein binds to KLK3 promoter]; PHB protein promotes the reaction [bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; PHB protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
JBrowse link
G Pip prolactin induced protein decreases expression
multiple interactions
ISO bicalutamide results in decreased expression of PIP mRNA
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of PIP mRNA]
CTD PMID:10402478 NCBI chr 4:71,320,859...71,325,153
Ensembl chr 4:71,320,859...71,325,153
JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO bicalutamide results in decreased expression of PRC1 mRNA CTD PMID:15638997 NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746
JBrowse link
G Pten phosphatase and tensin homolog multiple interactions
increases activity
ISO bicalutamide promotes the reaction [PTEN protein results in decreased expression of KLK3 mRNA]
bicalutamide results in increased activity of PTEN protein
CTD PMID:16637073 NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] CTD PMID:16317058 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Racgap1 Rac GTPase-activating protein 1 decreases expression ISO bicalutamide results in decreased expression of RACGAP1 mRNA CTD PMID:15638997 NCBI chr 7:141,277,303...141,308,849
Ensembl chr 7:141,277,312...141,307,233
JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO bicalutamide results in decreased expression of RANBP1 mRNA CTD PMID:15638997 NCBI chr11:86,890,585...86,898,818
Ensembl chr11:86,890,585...86,898,818
JBrowse link
G Rarb retinoic acid receptor, beta increases expression ISO bicalutamide results in increased expression of RARB mRNA CTD PMID:15790403 NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599
JBrowse link
G Rb1 RB transcriptional corepressor 1 increases phosphorylation ISO bicalutamide results in increased phosphorylation of RB1 protein CTD PMID:17599054 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
JBrowse link
G Rom1 retinal outer segment membrane protein 1 increases expression ISO bicalutamide results in increased expression of ROM1 mRNA CTD PMID:15790403 NCBI chr 1:225,126,732...225,128,740
Ensembl chr 1:225,126,734...225,128,740
JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6 protein CTD PMID:21036700 NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
Ensembl chr 5:105,197,857...105,200,148
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6KB1 protein CTD PMID:21036700 NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO bicalutamide results in decreased expression of RRM2 mRNA CTD PMID:15638997 NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
JBrowse link
G Rxrb retinoid X receptor beta decreases expression ISO bicalutamide results in decreased expression of RXRB CTD PMID:11845989 NCBI chr20:3,822,673...3,829,138
Ensembl chr20:3,823,042...3,829,140
JBrowse link
G Scgb2a1 secretoglobin, family 2A, member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SCGB2A1 mRNA] CTD PMID:16020486 NCBI chr 1:225,899,313...225,902,676
Ensembl chr 1:225,899,313...225,902,676
JBrowse link
G Sem1 SEM1 26S proteasome subunit increases expression ISO bicalutamide results in increased expression of SEM1 mRNA CTD PMID:16631469 NCBI chr 4:32,067,444...32,087,600
Ensembl chr 4:32,067,444...32,087,600
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINE1 mRNA]] CTD PMID:16317058 NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression ISO bicalutamide results in increased expression of SLC3A2 mRNA CTD PMID:15638997 NCBI chr 1:224,906,566...224,921,029
Ensembl chr 1:224,906,554...224,921,092
JBrowse link
G Slc4a4 solute carrier family 4 member 4 decreases expression ISO bicalutamide results in decreased expression of SLC4A4 mRNA CTD PMID:15638997 NCBI chr14:20,476,258...20,817,042
Ensembl chr14:20,479,323...20,920,286
JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO bicalutamide results in increased expression of SLC7A11 mRNA CTD PMID:15638997 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]; PHB protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468
JBrowse link
G Snap25 synaptosome associated protein 25 increases expression ISO bicalutamide results in increased expression of SNAP25 mRNA CTD PMID:15790403 NCBI chr 3:129,697,408...129,788,417
Ensembl chr 3:129,599,353...129,788,400
JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO bicalutamide results in increased expression of SORD mRNA CTD PMID:15790403 NCBI chr 3:114,176,127...114,207,368
Ensembl chr 3:114,176,309...114,207,366
JBrowse link
G Spint2 serine peptidase inhibitor, Kunitz type, 2 increases expression ISO bicalutamide results in increased expression of SPINT2 mRNA CTD PMID:15790403 NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892
JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO bicalutamide results in increased expression of SQSTM1 mRNA CTD PMID:15638997 NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
JBrowse link
G Stip1 stress-induced phosphoprotein 1 decreases expression ISO bicalutamide results in decreased expression of STIP1 mRNA CTD PMID:15638997 NCBI chr 1:222,274,133...222,293,139
Ensembl chr 1:222,274,133...222,293,148
JBrowse link
G Tamm41 TAM41 mitochondrial translocator assembly and maintenance homolog increases expression ISO bicalutamide results in increased expression of TAMM41 mRNA CTD PMID:16631469 NCBI chr 4:146,922,085...146,954,159
Ensembl chr 4:146,922,085...146,954,159
JBrowse link
G Tert telomerase reverse transcriptase decreases activity
decreases expression
ISO bicalutamide results in decreased activity of TERT protein
bicalutamide results in decreased expression of TERT mRNA
CTD PMID:15638997 NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO bicalutamide results in decreased expression of TK1 mRNA CTD PMID:15638997 NCBI chr10:106,817,556...106,828,888
Ensembl chr10:106,817,601...106,828,884
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]] CTD PMID:16317058 NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of TMEFF2 protein] CTD PMID:23405127 NCBI chr 9:55,379,130...55,673,704
Ensembl chr 9:55,384,100...55,673,829
JBrowse link
G Tmprss2 transmembrane serine protease 2 multiple interactions ISO [Goserelin co-treated with bicalutamide] results in decreased expression of TMPRSS2 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of TMPRSS2 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of TMPRSS2 protein; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of TMPRSS2 mRNA] CTD PMID:23708653 PMID:24323034 PMID:28757136 NCBI chr11:38,063,914...38,103,406
Ensembl chr11:38,063,915...38,103,290
JBrowse link
G Tmsb4x thymosin beta 4, X-linked multiple interactions
increases expression
ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of TMSB4X mRNA]
bicalutamide results in increased expression of TMSB4X mRNA
CTD PMID:17916567 NCBI chr  X:28,593,405...28,617,267
Ensembl chr  X:28,593,405...28,595,395
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions
ISO bicalutamide results in increased expression of TP53 protein
bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of TP53 protein]
CTD PMID:15638997 PMID:29383186 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tp53i3 tumor protein p53 inducible protein 3 increases expression ISO bicalutamide results in increased expression of TP53I3 mRNA CTD PMID:15638997 NCBI chr13:75,101,759...75,145,967
Ensembl chr13:75,105,615...75,143,441
JBrowse link
G Tpd52 tumor protein D52 decreases response to substance ISO TPD52 protein results in decreased susceptibility to bicalutamide CTD PMID:17875733 NCBI chr 2:94,959,732...95,041,277
Ensembl chr 2:95,008,311...95,040,514
JBrowse link
G Tpx2 TPX2, microtubule nucleation factor decreases expression ISO bicalutamide results in decreased expression of TPX2 mRNA CTD PMID:15638997 NCBI chr 3:148,327,965...148,370,187
Ensembl chr 3:148,327,965...148,370,187
JBrowse link
G Tram1 translocation associated membrane protein 1 increases expression ISO bicalutamide results in increased expression of TRAM1 mRNA CTD PMID:16631469 NCBI chr 5:5,215,196...5,297,337
Ensembl chr 5:5,215,196...5,316,685
JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO bicalutamide results in increased expression of TRIB3 mRNA CTD PMID:15638997 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
JBrowse link
G Tyms thymidylate synthetase decreases expression ISO bicalutamide results in decreased expression of TYMS protein CTD PMID:17599054 NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
JBrowse link
G Uap1 UDP-N-acetylglucosamine pyrophosphorylase 1 increases expression ISO bicalutamide results in increased expression of UAP1 mRNA CTD PMID:15790403 NCBI chr13:88,463,532...88,497,901
Ensembl chr13:88,463,532...88,497,901
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA CTD PMID:28500234 NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159
JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 decreases expression ISO bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
JBrowse link
G Upp1 uridine phosphorylase 1 increases expression ISO bicalutamide results in increased expression of UPP1 mRNA CTD PMID:15638997 NCBI chr14:89,314,234...89,334,060
Ensembl chr14:89,314,176...89,334,276
JBrowse link
G Uxt ubiquitously-expressed, prefoldin-like chaperone affects response to substance ISO UXT protein affects the susceptibility to bicalutamide CTD PMID:19318562 NCBI chr  X:1,275,402...1,287,781
Ensembl chr  X:1,275,612...1,287,512
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 increases expression ISO bicalutamide results in increased expression of WARS1 mRNA CTD PMID:15638997 NCBI chr 6:132,771,026...132,802,262
Ensembl chr 6:132,771,021...132,802,210
JBrowse link
G Ythdf3 YTH N(6)-methyladenosine RNA binding protein 3 increases expression ISO bicalutamide results in increased expression of YTHDF3 mRNA CTD PMID:16631469 NCBI chr 2:100,677,388...100,711,365
Ensembl chr 2:100,677,411...100,710,417
JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression ISO bicalutamide results in increased expression of ZMAT3 mRNA CTD PMID:15638997 NCBI chr 2:118,715,229...118,746,109
Ensembl chr 2:118,721,334...118,745,766
JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO bicalutamide results in decreased expression of ZWINT mRNA CTD PMID:15638997 NCBI chr20:17,075,781...17,091,715
Ensembl chr20:17,075,771...17,091,766
JBrowse link
dacomitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Egfr epidermal growth factor receptor multiple interactions ISO dacomitinib inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein] CTD PMID:27491023 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
epoxiconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase decreases expression ISO epoxiconazole results in decreased expression of AASS mRNA CTD PMID:22334560 NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA CTD PMID:29038839 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ABCB1A mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression EXP epoxiconazole results in increased expression of ABCB1B mRNA CTD PMID:25182419 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ABCC2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA
CTD PMID:29038839 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of ABCC3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 increases expression ISO epoxiconazole results in increased expression of ABCC4 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
JBrowse link
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B increases expression ISO epoxiconazole results in increased expression of ABHD4 mRNA CTD PMID:22334560 NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
Ensembl chr 3:10,041,826...10,144,388
JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of ACAA2 mRNA CTD PMID:22334560 NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 increases expression EXP epoxiconazole results in increased expression of ACAD9 mRNA CTD PMID:29038839 NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768
JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO epoxiconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA CTD PMID:29038839 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Acly ATP citrate lyase increases expression EXP epoxiconazole results in increased expression of ACLY mRNA CTD PMID:29038839 NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
JBrowse link
G Aco1 aconitase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA CTD PMID:29038839 NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218
JBrowse link
G Acot3 acyl-CoA thioesterase 3 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT3 mRNA CTD PMID:29038839 NCBI chr 6:107,531,508...107,537,446
Ensembl chr 6:107,531,528...107,536,789
JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA CTD PMID:29038839 NCBI chr  X:43,543,069...43,592,200
Ensembl chr  X:43,543,070...43,592,200
JBrowse link
G Acp2 acid phosphatase 2, lysosomal increases expression ISO epoxiconazole results in increased expression of ACP2 mRNA CTD PMID:22334560 NCBI chr 3:80,020,346...80,030,365
Ensembl chr 3:80,021,440...80,030,363
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO epoxiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA CTD PMID:25607892 NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
JBrowse link
G Adam11 ADAM metallopeptidase domain 11 increases expression ISO epoxiconazole results in increased expression of ADAM11 mRNA CTD PMID:22334560 NCBI chr10:90,731,260...90,749,221
Ensembl chr10:90,731,148...90,749,217
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) decreases expression EXP epoxiconazole results in decreased expression of ADH1 mRNA CTD PMID:29038839 NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
JBrowse link
G Adssl1 adenylosuccinate synthase like 1 increases expression ISO epoxiconazole results in increased expression of ADSSL1 mRNA CTD PMID:22334560 NCBI chr 6:137,184,818...137,206,694
Ensembl chr 6:137,184,820...137,206,693
JBrowse link
G Ahctf1 AT hook containing transcription factor 1 decreases expression ISO epoxiconazole results in decreased expression of AHCTF1 mRNA CTD PMID:22334560 NCBI chr13:98,023,528...98,079,138
Ensembl chr13:98,023,430...98,078,946
JBrowse link
G Ahr aryl hydrocarbon receptor increases expression ISO
EXP
epoxiconazole results in increased expression of AHR mRNA CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahsg alpha-2-HS-glycoprotein decreases expression ISO epoxiconazole results in decreased expression of AHSG mRNA CTD PMID:22334560 NCBI chr11:81,711,269...81,717,594 JBrowse link
G Akap1 A-kinase anchoring protein 1 decreases expression ISO epoxiconazole results in decreased expression of AKAP1 mRNA CTD PMID:22334560 NCBI chr10:76,151,013...76,183,987
Ensembl chr10:76,151,038...76,166,276
JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO epoxiconazole results in decreased expression of AKAP13 mRNA CTD PMID:22334560 NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272
JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO epoxiconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582
JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression ISO epoxiconazole results in increased expression of AKR1B7 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 4:61,850,256...61,879,733
Ensembl chr 4:61,850,348...61,862,526
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ALDH1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO epoxiconazole results in decreased expression of ALS2 mRNA CTD PMID:22334560 NCBI chr 9:65,961,361...66,034,396
Ensembl chr 9:65,961,346...66,033,871
JBrowse link
G Anxa10 annexin A10 increases expression ISO epoxiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465
JBrowse link
G Anxa7 annexin A7 increases expression ISO epoxiconazole results in increased expression of ANXA7 mRNA CTD PMID:22334560 NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA CTD PMID:29038839 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
JBrowse link
G Apoe apolipoprotein E increases expression EXP epoxiconazole results in increased expression of APOE mRNA CTD PMID:28454766 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G Apof apolipoprotein F multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA CTD PMID:29038839 NCBI chr 7:2,689,501...2,690,938
Ensembl chr 7:2,689,501...2,690,936
JBrowse link
G Ar androgen receptor multiple interactions ISO epoxiconazole inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arg1 arginase 1 decreases expression ISO epoxiconazole results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
JBrowse link
G Arl5a ADP-ribosylation factor like GTPase 5A decreases expression ISO epoxiconazole results in decreased expression of ARL5A mRNA CTD PMID:22334560 NCBI chr 3:37,922,544...37,947,434
Ensembl chr 3:37,924,793...37,947,283
JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 increases expression ISO epoxiconazole results in increased expression of ARPP19 mRNA CTD PMID:22334560 NCBI chr 8:81,949,577...81,972,054
Ensembl chr 8:81,949,877...81,968,589
JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO epoxiconazole results in increased expression of ASAH1 mRNA CTD PMID:22334560 NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA CTD PMID:29038839 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO epoxiconazole results in decreased expression of ATF5 mRNA CTD PMID:22334560 NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522
JBrowse link
G Atf6 activating transcription factor 6 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA CTD PMID:29038839 NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression ISO epoxiconazole results in increased expression of ATG16L2 mRNA CTD PMID:22334560 NCBI chr 1:166,401,271...166,415,078
Ensembl chr 1:166,401,271...166,413,564
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA
epoxiconazole results in increased expression of ATM mRNA
CTD PMID:29038839 NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 increases expression ISO epoxiconazole results in increased expression of ATP6V0E mRNA CTD PMID:22334560 NCBI chr10:16,769,857...16,792,930
Ensembl chr10:16,769,666...16,792,909
JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA
epoxiconazole results in increased expression of ATP8B1 mRNA
CTD PMID:29038839 NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
JBrowse link
G Atxn7l3b ataxin 7-like 3B decreases expression ISO epoxiconazole results in decreased expression of ATXN7L3B mRNA CTD PMID:22334560 NCBI chr 7:55,600,879...55,604,403
Ensembl chr 7:55,600,889...55,604,403
JBrowse link
G Bace1 beta-secretase 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
JBrowse link
G Bace2 beta-secretase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 NCBI chr11:37,798,397...37,880,624
Ensembl chr11:37,798,370...37,880,821
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of BHMT2 mRNA CTD PMID:22334560 NCBI chr 2:23,272,320...23,289,266
Ensembl chr 2:23,272,328...23,289,266
JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO epoxiconazole results in decreased expression of BID mRNA CTD PMID:22334560 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA CTD PMID:25607892 NCBI chr 8:116,873,721...116,965,396
Ensembl chr 8:116,873,721...116,965,396
JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO epoxiconazole results in decreased expression of C2CD2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr11:38,354,746...38,420,133
Ensembl chr11:38,357,424...38,420,119
JBrowse link
G C4b complement C4B (Chido blood group) decreases expression ISO epoxiconazole results in decreased expression of C4B mRNA CTD PMID:22334560 NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715
JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA CTD PMID:25607892 NCBI chr19:25,453,236...25,749,550
Ensembl chr19:25,526,751...25,749,550
JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA CTD PMID:25607892 NCBI chr 3:1,740,026...1,924,959
Ensembl chr 3:1,740,024...1,924,827
JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA CTD PMID:25607892 NCBI chr 4:150,635,808...151,270,790
Ensembl chr 4:150,641,066...150,829,913
JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA CTD PMID:25607892 NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117
JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA CTD PMID:25607892 NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848
JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA CTD PMID:25607892 NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283
JBrowse link
G Cacna2d3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA CTD PMID:25607892 NCBI chr16:4,871,348...5,795,825
Ensembl chr16:4,871,650...5,795,825
JBrowse link
G Cacnb1 calcium voltage-gated channel auxiliary subunit beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA CTD PMID:25607892 NCBI chr10:85,954,138...85,974,764
Ensembl chr10:85,954,138...85,974,651
JBrowse link
G Cacnb3 calcium voltage-gated channel auxiliary subunit beta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA CTD PMID:25607892 NCBI chr 7:140,311,120...140,324,902
Ensembl chr 7:140,315,368...140,324,902
JBrowse link
G Cacng2 calcium voltage-gated channel auxiliary subunit gamma 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA CTD PMID:25607892 NCBI chr 7:119,228,112...119,353,332
Ensembl chr 7:119,228,102...119,352,605
JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA CTD PMID:25607892 NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241
JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA CTD PMID:25607892 NCBI chr 1:64,374,547...64,405,380
Ensembl chr 1:64,374,603...64,405,149
JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA CTD PMID:25607892 NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA CTD PMID:25607892 NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
Ensembl chr15:3,936,786...3,995,915
JBrowse link
G Capns1 calpain, small subunit 1 increases expression ISO epoxiconazole results in increased expression of CAPNS1 mRNA CTD PMID:22334560 NCBI chr 1:91,058,528...91,064,880
Ensembl chr 1:88,652,446...88,657,845
JBrowse link
G Cars cysteinyl-tRNA synthetase decreases expression ISO epoxiconazole results in decreased expression of CARS mRNA CTD PMID:22334560 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656
JBrowse link
G Casp7 caspase 7 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA CTD PMID:29038839 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Cd36 CD36 molecule increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of CD36 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA CTD PMID:25607892 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
JBrowse link
G Cd81 Cd81 molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA CTD PMID:25607892 NCBI chr 1:216,237,663...216,253,460
Ensembl chr 1:216,237,697...216,253,311
JBrowse link
G Cdc34 cell division cycle 34, ubiqiutin conjugating enzyme increases expression ISO epoxiconazole results in increased expression of CDC34 mRNA CTD PMID:22334560 NCBI chr 7:12,899,957...12,905,339
Ensembl chr 7:12,899,958...12,905,339
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA CTD PMID:29038839 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression ISO epoxiconazole results in increased expression of CDS2 mRNA CTD PMID:22334560 NCBI chr 3:124,896,657...124,935,221
Ensembl chr 3:124,896,618...124,935,226
JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta decreases expression ISO epoxiconazole results in decreased expression of CEBPZ mRNA CTD PMID:22334560 NCBI chr 6:1,516,804...1,534,488
Ensembl chr 6:1,516,804...1,534,488
JBrowse link
G Ces2c carboxylesterase 2C increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CES2C mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CES2C mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CES2C mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 1:282,640,752...282,648,319
Ensembl chr 1:282,638,017...282,702,424
JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO epoxiconazole results in increased expression of CES2 mRNA CTD PMID:22334560 NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
JBrowse link
G Cggbp1 CGG triplet repeat binding protein 1 decreases expression ISO epoxiconazole results in decreased expression of CGGBP1 mRNA CTD PMID:22334560 NCBI chr11:1,896,166...1,915,603
Ensembl chr11:1,896,209...1,915,587
JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like increases expression ISO epoxiconazole results in increased expression of CHD1L mRNA CTD PMID:22334560 NCBI chr 2:199,714,044...199,792,270
Ensembl chr 2:199,716,713...199,771,896
JBrowse link
G Chga chromogranin A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA CTD PMID:25607892 NCBI chr 6:126,434,226...126,445,569
Ensembl chr 6:126,434,226...126,445,568
JBrowse link
G Chka choline kinase alpha decreases expression ISO epoxiconazole results in decreased expression of CHKA mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220
JBrowse link
G Chst1 carbohydrate sulfotransferase 1 decreases expression EXP epoxiconazole results in decreased expression of CHST1 mRNA CTD PMID:25182419 NCBI chr 3:81,441,785...81,512,829
Ensembl chr 3:81,498,022...81,512,807
JBrowse link
G Cmahp cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene decreases expression ISO epoxiconazole results in decreased expression of CMAH mRNA CTD PMID:22334560 NCBI chr17:42,567,472...42,640,221
Ensembl chr17:42,583,945...42,640,221
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA CTD PMID:29038839 NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089
JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression ISO epoxiconazole results in increased expression of CREG1 mRNA CTD PMID:22334560 NCBI chr13:83,972,186...83,984,675
Ensembl chr13:83,972,212...83,984,675
JBrowse link
G Crp C-reactive protein increases expression ISO epoxiconazole results in increased expression of CRP mRNA CTD PMID:22334560 NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
JBrowse link
G Ctsd cathepsin D increases expression ISO epoxiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
JBrowse link
G Ctse cathepsin E multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA CTD PMID:29038839 NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
JBrowse link
G Ctsl cathepsin L increases expression ISO epoxiconazole results in increased expression of CTSL mRNA CTD PMID:22334560 NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279
JBrowse link
G Ctso cathepsin O increases expression ISO epoxiconazole results in increased expression of CTSO mRNA CTD PMID:22334560 NCBI chr 2:180,857,178...180,881,677 JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO epoxiconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA CTD PMID:28454766 NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases expression EXP epoxiconazole results in increased expression of CYP11B2 mRNA CTD PMID:28454766 NCBI chr 7:116,155,928...116,161,781
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO
EXP
[prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA
CTD PMID:25233012 PMID:25607892 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity
EXP
ISO
epoxiconazole results in increased expression of CYP1A1 mRNA
[epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA
epoxiconazole results in increased activity of CYP1A1 protein
epoxiconazole results in increased expression of CYP1A1 mRNA; epoxiconazole results in increased expression of CYP1A1 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [epoxiconazole results in increased expression of CYP1A1 mRNA]; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein
CTD PMID:25182419 PMID:25233012 PMID:29038839 PMID:29294346 PMID:32194361 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression
multiple interactions
increases activity
ISO
EXP
epoxiconazole results in increased expression of CYP2B10 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA
epoxiconazole results in increased activity of CYP2B1 protein
epoxiconazole results in increased expression of CYP2B1 mRNA
CTD PMID:22334560 PMID:23970803 PMID:25182419 PMID:29038839 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 increases expression EXP epoxiconazole results in increased expression of CYP2B15 mRNA CTD PMID:25182419 NCBI chr 1:251,325,923...251,338,404
Ensembl chr 1:251,325,923...251,338,358
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CYP2B2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP2B2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B2 mRNA
CTD PMID:29038839 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression
multiple interactions
ISO epoxiconazole results in increased expression of CYP2B9 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein
CTD PMID:22334560 PMID:23970803 PMID:29294346 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression EXP epoxiconazole results in increased expression of CYP2C11 mRNA CTD PMID:29038839 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 increases expression ISO epoxiconazole results in increased expression of CYP2C55 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases expression
decreases expression
EXP
ISO
epoxiconazole results in increased expression of CYP2C6V1 mRNA
epoxiconazole results in decreased expression of CYP2C19 protein
CTD PMID:25182419 PMID:32194361 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA CTD PMID:29038839 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CYP3A2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA
CTD PMID:29038839 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression
multiple interactions
increases activity
EXP epoxiconazole results in increased expression of CYP3A23-3A1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein; [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein
epoxiconazole results in increased activity of CYP3A23-3A1 protein
CTD PMID:25182419 PMID:29038839 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions
increases expression
ISO [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 protein
epoxiconazole results in increased expression of CYP3A4 mRNA; epoxiconazole results in increased expression of CYP3A4 protein
CTD PMID:29294346 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 increases expression EXP epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089
JBrowse link
G Cyp51 cytochrome P450, family 51 decreases activity ISO epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression
EXP
ISO
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA
epoxiconazole results in decreased expression of CYP7A1 mRNA
CTD PMID:29038839 PMID:32194361 NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression ISO epoxiconazole results in decreased expression of DBT mRNA CTD PMID:22334560 NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650
JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA CTD PMID:25607892 NCBI chr18:66,518,213...67,629,801
Ensembl chr18:66,523,120...67,224,566
JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression ISO epoxiconazole results in increased expression of DDOST mRNA CTD PMID:22334560 NCBI chr 5:156,668,924...156,676,036
Ensembl chr 5:156,668,712...156,676,035
JBrowse link
G Ddx46 DEAD-box helicase 46 decreases expression ISO epoxiconazole results in decreased expression of DDX46 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:9,475,275...9,519,545
Ensembl chr17:9,475,538...9,519,595
JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO epoxiconazole results in decreased expression of DDX6 mRNA CTD PMID:22334560 NCBI chr 8:48,924,768...48,961,394
Ensembl chr 8:48,925,604...48,958,026
JBrowse link
G Dexi Dexi homolog decreases expression ISO epoxiconazole results in decreased expression of DEXI mRNA CTD PMID:22334560 NCBI chr10:5,199,226...5,211,913
Ensembl chr10:5,199,226...5,211,913
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression EXP epoxiconazole results in increased expression of DLAT mRNA CTD PMID:29038839 NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA CTD PMID:25607892 NCBI chr11:72,164,566...72,378,895
Ensembl chr11:72,163,749...72,378,895
JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA CTD PMID:25607892 NCBI chr10:56,625,845...56,655,543
Ensembl chr10:56,627,411...56,653,599
JBrowse link
G Dlgap3 DLG associated protein 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA CTD PMID:25607892 NCBI chr 5:145,234,757...145,304,536
Ensembl chr 5:145,257,714...145,304,536
JBrowse link
G Dlgap4 DLG associated protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA CTD PMID:25607892 NCBI chr 3:152,752,091...152,846,118
Ensembl chr 3:152,752,091...152,846,118
JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression ISO epoxiconazole results in decreased expression of DMGDH mRNA CTD PMID:22334560 NCBI chr 2:23,289,376...23,370,360
Ensembl chr 2:23,289,374...23,370,477
JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 decreases expression ISO epoxiconazole results in decreased expression of DNAI1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:57,947,796...58,017,985
Ensembl chr 5:57,947,716...58,017,992
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression EXP epoxiconazole results in increased expression of DNAJB1 mRNA CTD PMID:29038839 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
JBrowse link
G Doc2a double C2 domain alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA CTD PMID:25607892 NCBI chr 1:198,282,828...198,288,611
Ensembl chr 1:198,284,473...198,288,113
JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO epoxiconazole results in increased expression of DPAGT1 mRNA CTD PMID:22334560 NCBI chr 8:48,657,779...48,664,531
Ensembl chr 8:48,657,795...48,664,860
JBrowse link
G Dpp10 dipeptidyl peptidase like 10 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA CTD PMID:25607892 NCBI chr13:39,430,590...41,173,706
Ensembl chr13:39,434,217...39,643,361
JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA CTD PMID:25607892 NCBI chr 4:4,021,021...4,943,675
Ensembl chr 4:4,021,008...4,473,307
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA CTD PMID:25607892 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression ISO epoxiconazole results in increased expression of DUSP3 mRNA CTD PMID:22334560 NCBI chr10:89,904,578...89,918,296
Ensembl chr10:89,904,560...89,918,427
JBrowse link
G Egf epidermal growth factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA CTD PMID:25607892 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA CTD PMID:25607892 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egr1 early growth response 1 decreases expression EXP epoxiconazole results in decreased expression of EGR1 mRNA CTD PMID:28454766 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP epoxiconazole results in decreased expression of EHD1 mRNA CTD PMID:28454766 NCBI chr 1:221,644,867...221,667,242
Ensembl chr 1:221,644,867...221,667,239
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA CTD PMID:29038839 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of EIF2AK3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA
CTD PMID:29038839 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 decreases expression ISO epoxiconazole results in decreased expression of EIF4G2 mRNA CTD PMID:22334560 NCBI chr 1:175,883,362...175,895,510
Ensembl chr 1:175,883,363...175,895,510
JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO epoxiconazole results in increased expression of ELOVL1 mRNA CTD PMID:22334560 NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483
JBrowse link
G Enho energy homeostasis associated decreases expression ISO epoxiconazole results in decreased expression of ENHO mRNA CTD PMID:22334560 NCBI chr 5:58,018,039...58,019,836
Ensembl chr 5:58,018,039...58,019,836
JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression ISO epoxiconazole results in increased expression of ENTPD5 mRNA CTD PMID:22334560 NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA CTD PMID:29038839 NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of EPHX1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA
CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
JBrowse link
G Ephx2 epoxide hydrolase 2 decreases expression ISO epoxiconazole results in decreased expression of EPHX2 mRNA CTD PMID:22334560 NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA CTD PMID:25607892 NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA CTD PMID:25607892 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA CTD PMID:25607892 NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
JBrowse link
G Etfa electron transfer flavoprotein subunit alpha decreases expression ISO epoxiconazole results in decreased expression of ETFA mRNA CTD PMID:22334560 NCBI chr 8:60,028,786...60,086,352
Ensembl chr 8:60,028,789...60,086,403
JBrowse link
G Etnppl ethanolamine-phosphate phospho-lyase decreases expression ISO epoxiconazole results in decreased expression of ETNPPL mRNA CTD PMID:22334560 NCBI chr 2:235,738,377...235,760,351
Ensembl chr 2:235,738,416...235,760,352
JBrowse link
G Exosc8 exosome component 8 increases expression ISO epoxiconazole results in increased expression of EXOSC8 mRNA CTD PMID:22334560 NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940
JBrowse link
G F10 coagulation factor X increases expression ISO epoxiconazole results in increased expression of F10 mRNA CTD PMID:22334560 NCBI chr16:81,803,169...81,822,476
Ensembl chr16:81,803,110...81,822,716
JBrowse link
G F5 coagulation factor V decreases expression ISO epoxiconazole results in decreased expression of F5 mRNA CTD PMID:22334560 NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO epoxiconazole results in decreased expression of FAH mRNA CTD PMID:22334560 NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261
JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression ISO epoxiconazole results in increased expression of FAM114A1 mRNA CTD PMID:22334560 NCBI chr14:44,941,705...45,012,299
Ensembl chr14:44,943,172...45,002,719
JBrowse link
G Fam168a family with sequence similarity 168, member A decreases expression ISO epoxiconazole results in decreased expression of FAM168A mRNA CTD PMID:22334560 NCBI chr 1:165,723,278...165,880,612
Ensembl chr 1:165,724,451...165,878,652
JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA CTD PMID:29038839 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Fasn fatty acid synthase increases expression EXP epoxiconazole results in increased expression of FASN mRNA CTD PMID:29038839 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fez2 fasciculation and elongation protein zeta 2 increases expression ISO epoxiconazole results in increased expression of FEZ2 mRNA CTD PMID:22334560 NCBI chr 6:963,903...1,003,955
Ensembl chr 6:963,907...1,004,001
JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of FGF1 mRNA CTD PMID:22334560 NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
JBrowse link
G Fmr1 FMRP translational regulator 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA CTD PMID:25607892 NCBI chr  X:154,684,924...154,722,369
Ensembl chr  X:154,684,935...154,722,314
JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA CTD PMID:25607892 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 increases expression ISO epoxiconazole results in increased expression of G3BP2 mRNA CTD PMID:22334560 NCBI chr14:17,437,145...17,523,254
Ensembl chr14:17,492,081...17,520,792
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA CTD PMID:25607892 NCBI chr14:39,154,072...39,230,994
Ensembl chr14:39,154,529...39,231,695
JBrowse link
G Gabrb1 gamma-aminobutyric acid type A receptor subunit beta1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA CTD PMID:25607892 NCBI chr14:38,631,192...39,112,598
Ensembl chr14:38,643,385...39,112,600
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO epoxiconazole results in increased expression of GADD45B mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO epoxiconazole results in increased expression of GCH1 mRNA CTD PMID:22334560 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA CTD PMID:25607892 NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
JBrowse link
G Ghr growth hormone receptor decreases expression ISO epoxiconazole results in decreased expression of GHR mRNA CTD PMID:22334560 NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638
JBrowse link
G Glrx glutaredoxin increases expression ISO epoxiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO epoxiconazole results in increased expression of GLRX5 mRNA CTD PMID:22334560 NCBI chr 6:128,750,503...128,760,880
Ensembl chr 6:128,750,795...128,760,880
JBrowse link
G Gls glutaminase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
JBrowse link
G Gls2 glutaminase 2 decreases expression ISO epoxiconazole results in decreased expression of GLS2 mRNA CTD PMID:22334560 NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852
JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression ISO epoxiconazole results in decreased expression of GLUD1 mRNA CTD PMID:22334560 NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
JBrowse link
G Gpc1 glypican 1 decreases expression EXP epoxiconazole results in decreased expression of GPC1 mRNA CTD PMID:28454766 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP epoxiconazole results in increased expression of GPD1 mRNA CTD PMID:29038839 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression ISO epoxiconazole results in increased expression of GPX4 mRNA CTD PMID:22334560 NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA CTD PMID:25607892 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA CTD PMID:25607892 NCBI chr 8:1,548,145...2,045,874
Ensembl chr 8:1,548,146...2,045,817
JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA CTD PMID:25607892 NCBI chr11:27,811,954...28,213,940
Ensembl chr11:27,811,957...27,971,359
JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA CTD PMID:25607892 NCBI chr20:53,791,428...54,517,691
Ensembl chr20:53,789,760...54,517,709
JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA CTD PMID:25607892 NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA CTD PMID:25607892 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
JBrowse link
G Grip1 glutamate receptor interacting protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA CTD PMID:25607892 NCBI chr 7:64,672,723...64,854,939
Ensembl chr 7:64,672,722...64,864,404
JBrowse link
G Grn granulin precursor decreases expression ISO epoxiconazole results in decreased expression of GRN mRNA CTD PMID:22334560 NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP epoxiconazole results in increased expression of GSR mRNA CTD PMID:25182419 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
JBrowse link
G Gsta3 glutathione S-transferase alpha 3 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 9:27,357,490...27,417,023
Ensembl chr 9:27,402,381...27,417,023
JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP
ISO
epoxiconazole results in increased expression of GSTM1 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression EXP
ISO
epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
JBrowse link
G Gstm4 glutathione S-transferase mu 4 increases expression ISO epoxiconazole results in increased expression of GSTM4 mRNA CTD PMID:22334560 NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
JBrowse link
G Gstm5 glutathione S-transferase, mu 5 increases expression ISO epoxiconazole results in increased expression of GSTM3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP epoxiconazole results in increased expression of GSTP1 mRNA CTD PMID:25182419 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression ISO epoxiconazole results in increased expression of GSTT1 mRNA CTD PMID:22334560 NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase decreases expression ISO epoxiconazole results in decreased expression of HAAO mRNA CTD PMID:22334560 NCBI chr 6:7,045,145...7,059,227
Ensembl chr 6:7,045,152...7,058,314
JBrowse link
G Hacd1 3-hydroxyacyl-CoA dehydratase 1 increases expression ISO epoxiconazole results in increased expression of HACD1 mRNA CTD PMID:22334560 NCBI chr17:81,173,238...81,196,012
Ensembl chr17:81,173,713...81,187,739
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA CTD PMID:29038839 NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
JBrowse link
G Hal histidine ammonia lyase decreases expression ISO epoxiconazole results in decreased expression of HAL mRNA CTD PMID:22334560 NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
JBrowse link
G Hao1 hydroxyacid oxidase 1 decreases expression ISO epoxiconazole results in decreased expression of HAO1 mRNA CTD PMID:22334560 NCBI chr 3:127,444,900...127,500,709
Ensembl chr 3:127,444,902...127,500,709
JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 decreases expression ISO epoxiconazole results in decreased expression of HECTD1 mRNA CTD PMID:22334560 NCBI chr 6:72,509,658...72,596,285
Ensembl chr 6:72,510,255...72,596,446
JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 decreases expression ISO epoxiconazole results in decreased expression of HECTD2 mRNA CTD PMID:22334560 NCBI chr 1:255,186,729...255,254,307
Ensembl chr 1:255,185,629...255,254,307
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HERPUD1 mRNA CTD PMID:29038839 NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254
JBrowse link
G Hes6 hes family bHLH transcription factor 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA CTD PMID:25607892 NCBI chr 9:98,549,698...98,551,438
Ensembl chr 9:98,549,705...98,551,438
JBrowse link
G Higd1c HIG1 hypoxia inducible domain family, member 1C increases expression ISO epoxiconazole results in increased expression of HIGD1C mRNA CTD PMID:22334560 NCBI chr 7:142,000,612...142,021,344
Ensembl chr 7:142,001,338...142,020,705
JBrowse link
G Hmgn1 high mobility group nucleosome binding domain 1 increases expression ISO epoxiconazole results in increased expression of HMGN1 mRNA CTD PMID:22334560 NCBI chr11:36,474,028...36,479,947
Ensembl chr11:36,474,840...36,479,868
Ensembl chr11:36,474,840...36,479,868
JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases expression ISO epoxiconazole results in increased expression of HPRT mRNA CTD PMID:22334560 NCBI chr  X:158,196,640...158,228,815
Ensembl chr  X:158,197,149...158,228,749
Ensembl chr  X:158,197,149...158,228,749
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 increases expression EXP epoxiconazole results in increased expression of HSD17B2 mRNA CTD PMID:25182419 NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 increases expression ISO epoxiconazole results in increased expression of HSPA13 mRNA CTD PMID:22334560 NCBI chr11:14,146,515...14,160,697
Ensembl chr11:14,144,130...14,160,892
JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of HSPB8 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA
CTD PMID:29038839 NCBI chr12:45,905,371...45,920,014
Ensembl chr12:45,905,371...45,920,013
JBrowse link
G Ifnar2 interferon alpha and beta receptor subunit 2 increases expression ISO epoxiconazole results in increased expression of IFNAR2 mRNA CTD PMID:22334560 NCBI chr11:31,527,790...31,559,834
Ensembl chr11:31,539,016...31,558,851
JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of IGF1 mRNA CTD PMID:22334560 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA CTD PMID:25607892 NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477
JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit decreases expression ISO epoxiconazole results in decreased expression of IGFALS mRNA CTD PMID:22334560 NCBI chr10:14,240,308...14,243,554
Ensembl chr10:14,240,219...14,243,597
JBrowse link
G Ikbke inhibitor of nuclear factor kappa B kinase subunit epsilon increases expression ISO epoxiconazole results in increased expression of IKBKE mRNA CTD PMID:22334560 PMID:23970803 NCBI chr13:48,031,325...48,056,394
Ensembl chr13:48,031,410...48,056,394
JBrowse link
G Il1rap interleukin 1 receptor accessory protein decreases expression ISO epoxiconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 NCBI chr11:77,456,648...77,593,208
Ensembl chr11:77,463,954...77,593,207
JBrowse link
G Il1rapl1 interleukin 1 receptor accessory protein-like 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA CTD PMID:25607892 NCBI chr  X:55,439,388...57,004,865
Ensembl chr  X:55,439,578...56,765,893
JBrowse link
G Impact impact RWD domain protein increases expression ISO epoxiconazole results in increased expression of IMPACT mRNA CTD PMID:22334560 NCBI chr18:4,325,872...4,346,734
Ensembl chr18:4,325,875...4,346,769
JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 decreases expression ISO epoxiconazole results in decreased expression of IMPDH2 mRNA CTD PMID:22334560 NCBI chr 8:117,346,983...117,351,619
Ensembl chr 8:117,347,029...117,351,610
JBrowse link
G Itgax integrin subunit alpha X multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ITGAX mRNA CTD PMID:29038839 NCBI chr 1:199,555,560...199,576,948
Ensembl chr 1:199,555,722...199,576,932
JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 decreases expression ISO epoxiconazole results in decreased expression of ITIH1 mRNA CTD PMID:22334560 NCBI chr16:7,012,376...7,026,542
Ensembl chr16:7,012,354...7,026,540
JBrowse link
G Itih2 inter-alpha-trypsin inhibitor heavy chain 2 decreases expression ISO epoxiconazole results in decreased expression of ITIH2 mRNA CTD PMID:22334560 NCBI chr17:72,160,734...72,197,248
Ensembl chr17:72,160,735...72,195,509
JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 decreases expression ISO epoxiconazole results in decreased expression of ITIH3 mRNA CTD PMID:22334560 NCBI chr16:6,983,779...7,007,288
Ensembl chr16:6,992,062...7,007,287
JBrowse link
G Itm2c integral membrane protein 2C increases expression ISO epoxiconazole results in increased expression of ITM2C mRNA CTD PMID:22334560 NCBI chr 9:92,916,469...92,930,306
Ensembl chr 9:92,916,469...92,930,279
JBrowse link
G Ldha lactate dehydrogenase A decreases expression ISO epoxiconazole results in decreased expression of LDHA mRNA CTD PMID:22334560 NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
JBrowse link
G Ldlr low density lipoprotein receptor increases expression EXP epoxiconazole results in increased expression of LDLR mRNA CTD PMID:28454766 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G Lonrf3 LON peptidase N-terminal domain and ring finger 3 decreases expression ISO epoxiconazole results in decreased expression of LONRF3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr  X:122,937,987...122,973,289
Ensembl chr  X:122,938,009...122,973,321
JBrowse link
G Lrat lecithin retinol acyltransferase decreases expression ISO epoxiconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
JBrowse link
G Lrrc3 leucine rich repeat containing 3 decreases expression ISO epoxiconazole results in decreased expression of LRRC3 mRNA CTD PMID:22334560 NCBI chr20:11,488,514...11,491,354
Ensembl chr20:11,489,456...11,490,406
JBrowse link
G Lrrc7 leucine rich repeat containing 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA CTD PMID:25607892 NCBI chr 2:264,910,594...265,300,860
Ensembl chr 2:264,910,594...265,300,868
JBrowse link
G Lss lanosterol synthase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of LSS mRNA CTD PMID:29038839 NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor decreases expression ISO epoxiconazole results in decreased expression of LUC7L3 mRNA CTD PMID:22334560 NCBI chr10:81,991,147...82,027,119
Ensembl chr10:81,991,147...82,027,119
JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase increases expression ISO epoxiconazole results in increased expression of MAEA mRNA CTD PMID:22334560 NCBI chr14:82,664,248...82,697,673
Ensembl chr14:82,664,249...82,697,673
JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA CTD PMID:25607892 NCBI chr 4:10,995,241...12,472,423
Ensembl chr 4:10,995,234...11,610,518
JBrowse link
G Magt1 magnesium transporter 1 increases expression ISO epoxiconazole results in increased expression of MAGT1 mRNA CTD PMID:22334560 NCBI chr  X:77,023,423...77,061,603
Ensembl chr  X:77,020,402...77,061,667
JBrowse link
G Manba mannosidase beta multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA CTD PMID:29038839 NCBI chr 2:240,668,213...240,760,264
Ensembl chr 2:240,668,195...240,760,261
JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 increases expression ISO epoxiconazole results in increased expression of MBNL2 mRNA CTD PMID:22334560 NCBI chr15:105,640,097...105,797,933
Ensembl chr15:105,640,097...105,797,932
JBrowse link
G Mdga2 MAM domain containing glycosylphosphatidylinositol anchor 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA CTD PMID:25607892 NCBI chr 6:88,442,620...89,292,454
Ensembl chr 6:88,447,749...88,917,070
JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions
EXP epoxiconazole results in increased expression of MDM2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA
CTD PMID:29038839 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression ISO epoxiconazole results in increased expression of MEIG1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:78,813,656...78,829,411
Ensembl chr17:78,817,529...78,829,411
JBrowse link
G Mesd mesoderm development LRP chaperone increases expression ISO epoxiconazole results in increased expression of MESD mRNA CTD PMID:22334560 NCBI chr 1:146,030,211...146,043,097
Ensembl chr 1:146,037,426...146,043,097
JBrowse link
G Mettl7a methyltransferase like 7A increases expression ISO epoxiconazole results in increased expression of METTL7A1 mRNA CTD PMID:22334560 NCBI chr 7:141,973,447...142,021,344
Ensembl chr 7:141,973,553...141,981,432
JBrowse link
G Mfsd11 major facilitator superfamily domain containing 11 increases expression ISO epoxiconazole results in increased expression of MFSD11 mRNA CTD PMID:22334560 NCBI chr10:105,796,108...105,815,696
Ensembl chr10:105,796,680...105,815,696
JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression ISO epoxiconazole results in increased expression of MKI67 protein CTD PMID:22334560 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
JBrowse link
G Mlec malectin increases expression ISO epoxiconazole results in increased expression of MLEC mRNA CTD PMID:22334560 NCBI chr12:47,219,071...47,233,769
Ensembl chr12:47,218,969...47,252,286
JBrowse link
G Mlx MAX dimerization protein MLX multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MLX mRNA CTD PMID:29038839 NCBI chr10:88,997,011...89,002,154
Ensembl chr10:88,997,399...89,002,152
JBrowse link
G Morc3 MORC family CW-type zinc finger 3 increases expression ISO epoxiconazole results in increased expression of MORC3 mRNA CTD PMID:22334560 NCBI chr11:34,051,928...34,094,697
Ensembl chr11:34,051,993...34,094,698
JBrowse link
G Mrpl54 mitochondrial ribosomal protein L54 increases expression ISO epoxiconazole results in increased expression of MRPL54 mRNA CTD PMID:22334560 NCBI chr 7:11,321,057...11,323,577
Ensembl chr 7:11,321,057...11,323,577
JBrowse link
G Mrps18b mitochondrial ribosomal protein S18B multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA CTD PMID:29038839 NCBI chr20:3,344,870...3,350,929
Ensembl chr20:3,344,870...3,350,927
JBrowse link
G Msmo1 methylsterol monooxygenase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MSMO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MSMO1 mRNA CTD PMID:29038839 NCBI chr16:26,859,441...26,875,880
Ensembl chr16:26,859,397...26,875,973
JBrowse link
G Mt2A metallothionein 2A increases expression ISO epoxiconazole results in increased expression of MT2 mRNA CTD PMID:22334560 NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
JBrowse link
G Mthfr methylenetetrahydrofolate reductase increases expression EXP epoxiconazole results in increased expression of MTHFR mRNA CTD PMID:25182419 NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
JBrowse link
G Mug1 murinoglobulin 1 decreases expression ISO epoxiconazole results in decreased expression of MUG1 mRNA CTD PMID:22334560 NCBI chr 4:154,676,382...154,729,288
Ensembl chr 4:154,391,647...154,729,310
JBrowse link
G Myo1b myosin Ib decreases expression ISO epoxiconazole results in decreased expression of MYO1B mRNA CTD PMID:22334560 NCBI chr 9:54,706,005...54,766,054
Ensembl chr 9:54,558,202...54,766,054
JBrowse link
G Nagk N-acetylglucosamine kinase increases expression ISO epoxiconazole results in increased expression of NAGK mRNA CTD PMID:22334560 NCBI chr 4:115,473,848...115,485,027
Ensembl chr 4:115,473,811...115,481,438
JBrowse link
G Naprt nicotinate phosphoribosyltransferase decreases expression ISO epoxiconazole results in decreased expression of NAPRT mRNA CTD PMID:22334560 NCBI chr 7:116,922,979...116,926,436
Ensembl chr 7:116,922,944...116,926,555
JBrowse link
G Nat8 N-acetyltransferase 8 decreases expression ISO epoxiconazole results in decreased expression of NAT8 mRNA CTD PMID:22334560 NCBI chr 4:117,525,963...117,527,443 JBrowse link
G Nat8f1 N-acetyltransferase 8 (GCN5-related) family member 1 decreases expression ISO epoxiconazole results in decreased expression of NAT8F1 mRNA CTD PMID:22334560 NCBI chr 4:117,582,779...117,589,464
Ensembl chr 4:117,582,781...117,589,464
Ensembl chr 4:117,582,781...117,589,464
JBrowse link
G Nbr1 NBR1, autophagy cargo receptor decreases expression ISO epoxiconazole results in decreased expression of NBR1 mRNA CTD PMID:22334560 NCBI chr10:89,455,202...89,483,791
Ensembl chr10:89,459,650...89,484,080
JBrowse link
G Ndrg1 N-myc downstream regulated 1 increases expression ISO epoxiconazole results in increased expression of NDRG1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:107,734,326...107,775,701
Ensembl chr 7:107,734,323...107,775,714
JBrowse link
G Ndst1 N-deacetylase and N-sulfotransferase 1 decreases expression ISO epoxiconazole results in decreased expression of NDST1 mRNA CTD PMID:22334560 NCBI chr18:55,951,497...56,014,107
Ensembl chr18:55,955,389...55,992,885
JBrowse link
G Nebl nebulette increases expression ISO epoxiconazole results in increased expression of NEBL mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:84,141,014...84,247,038
Ensembl chr17:84,140,489...84,488,601
JBrowse link
G Nf1 neurofibromin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA CTD PMID:25607892 NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO epoxiconazole results in increased activity of NFE2L2 protein CTD PMID:30114225 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfib nuclear factor I/B decreases expression ISO epoxiconazole results in decreased expression of NFIB mRNA CTD PMID:22334560 NCBI chr 5:100,436,343...100,647,962
Ensembl chr 5:100,439,082...100,647,727
JBrowse link
G Nlgn1 neuroligin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA CTD PMID:25607892 NCBI chr 2:111,057,291...111,973,681
Ensembl chr 2:111,057,291...111,793,326
JBrowse link
G Notch2 notch receptor 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA CTD PMID:25607892 NCBI chr 2:200,187,184...200,320,403
Ensembl chr 2:200,187,179...200,320,215
JBrowse link
G Notch3 notch receptor 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA CTD PMID:25607892 NCBI chr 7:14,138,495...14,189,688
Ensembl chr 7:14,138,495...14,189,688
JBrowse link
G Notch4 notch receptor 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA CTD PMID:25607892 NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
JBrowse link
G Nploc4 NPL4 homolog, ubiquitin recognition factor increases expression
multiple interactions
EXP epoxiconazole results in increased expression of NPLOC4 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NPLOC4 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NPLOC4 mRNA
CTD PMID:29038839 NCBI chr10:109,553,518...109,610,087
Ensembl chr10:109,552,649...109,610,030
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of NQO1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NQO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NQO1 mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 decreases expression ISO epoxiconazole results in decreased expression of NR1I3 mRNA CTD PMID:25949234 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Nrcam neuronal cell adhesion molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA CTD PMID:25607892 NCBI chr 6:64,297,843...64,867,408
Ensembl chr 6:64,297,888...64,864,996
JBrowse link
G Nrg1 neuregulin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
JBrowse link
G Nrxn1 neurexin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA CTD PMID:25607892 NCBI chr 6:13,886,757...15,191,660
Ensembl chr 6:13,886,740...15,191,660
JBrowse link
G Nrxn2 neurexin 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA CTD PMID:25607892 NCBI chr 1:221,792,191...221,908,047
Ensembl chr 1:221,792,221...221,908,049
JBrowse link
G Nsfl1c NSFL1 cofactor increases expression ISO epoxiconazole results in increased expression of NSFL1C mRNA CTD PMID:22334560 NCBI chr 3:146,980,923...147,005,478
Ensembl chr 3:146,980,923...147,005,439
JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex increases expression ISO epoxiconazole results in increased expression of NSL1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr13:109,669,646...109,697,849
Ensembl chr13:109,669,680...109,696,918
JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like increases expression ISO epoxiconazole results in increased expression of OASL1 mRNA CTD PMID:22334560 NCBI chr12:47,444,138...47,456,680
Ensembl chr12:47,444,104...47,456,894
JBrowse link
G Obp2a odorant binding protein 2A decreases expression ISO epoxiconazole results in decreased expression of OBP2A mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 3:2,908,684...2,913,362
Ensembl chr 3:2,910,083...2,913,362
JBrowse link
G Ost4 oligosaccharyltransferase complex subunit 4, non-catalytic increases expression ISO epoxiconazole results in increased expression of OST4 mRNA CTD PMID:22334560 NCBI chr 6:26,836,216...26,837,440
Ensembl chr 6:26,836,216...26,837,440
JBrowse link
G P2rx4 purinergic receptor P2X 4 increases expression ISO epoxiconazole results in increased expression of P2RX4 mRNA CTD PMID:22334560 NCBI chr12:39,308,022...39,325,673
Ensembl chr12:39,308,025...39,325,673
JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 increases expression ISO epoxiconazole results in increased expression of PAPSS2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:251,145,264...251,230,716
Ensembl chr 1:251,145,253...251,230,715
JBrowse link
G Pc pyruvate carboxylase decreases expression ISO epoxiconazole results in decreased expression of PCX mRNA CTD PMID:22334560 NCBI chr 1:219,759,157...219,859,854
Ensembl chr 1:219,759,183...219,859,848
JBrowse link
G Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 decreases expression ISO epoxiconazole results in decreased expression of PCMTD1 mRNA CTD PMID:22334560 NCBI chr 5:12,132,657...12,204,376
Ensembl chr 5:12,132,657...12,199,283
JBrowse link
G Pepd peptidase D increases expression ISO epoxiconazole results in increased expression of PEPD mRNA CTD PMID:22334560 NCBI chr 1:90,820,670...91,285,128 JBrowse link
G Pgr progesterone receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA CTD PMID:25607892 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Pipox pipecolic acid and sarcosine oxidase decreases expression ISO epoxiconazole results in decreased expression of PIPOX mRNA CTD PMID:22334560 NCBI chr10:64,951,986...64,964,865
Ensembl chr10:64,952,119...64,964,862
JBrowse link
G Pla2g12a phospholipase A2, group XIIA increases expression ISO epoxiconazole results in increased expression of PLA2G12A mRNA CTD PMID:22334560 NCBI chr 2:235,311,664...235,327,972
Ensembl chr 2:235,311,719...235,327,972
JBrowse link
G Pla2g6 phospholipase A2 group VI increases expression ISO epoxiconazole results in increased expression of PLA2G6 mRNA CTD PMID:22334560 NCBI chr 7:120,519,479...120,559,716
Ensembl chr 7:120,519,467...120,559,347
JBrowse link
G Plbd1 phospholipase B domain containing 1 increases expression ISO epoxiconazole results in increased expression of PLBD1 mRNA CTD PMID:22334560 NCBI chr 4:170,564,387...170,620,681
Ensembl chr 4:170,564,367...170,620,703
JBrowse link
G Plin2 perilipin 2 decreases expression EXP epoxiconazole results in decreased expression of PLIN2 mRNA CTD PMID:28454766 NCBI chr 5:104,984,413...105,010,863
Ensembl chr 5:104,984,414...105,010,857
JBrowse link
G Plin5 perilipin 5 decreases expression ISO epoxiconazole results in decreased expression of PLIN5 mRNA CTD PMID:22334560 NCBI chr 9:10,956,013...10,961,782
Ensembl chr 9:10,956,056...10,961,782
JBrowse link
G Pnpla7 patatin-like phospholipase domain containing 7 decreases expression ISO epoxiconazole results in decreased expression of PNPLA7 mRNA CTD PMID:22334560 NCBI chr 3:2,182,191...2,261,890
Ensembl chr 3:2,182,957...2,261,878
Ensembl chr 3:2,182,957...2,261,878
JBrowse link
G Pon3 paraoxonase 3 increases expression ISO epoxiconazole results in increased expression of PON3 mRNA CTD PMID:22334560 NCBI chr 4:30,311,981...30,338,679
Ensembl chr 4:30,311,982...30,338,679
JBrowse link
G Por cytochrome p450 oxidoreductase increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of POR mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of POR mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of POR mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression ISO epoxiconazole results in decreased expression of PPARA mRNA CTD PMID:22334560 PMID:25689681 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of PPARGC1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of PPARGC1A mRNA
epoxiconazole results in increased expression of PPARGC1A mRNA
CTD PMID:29038839 NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
JBrowse link
G Ppm1k protein phosphatase, Mg2+/Mn2+ dependent, 1K decreases expression ISO epoxiconazole results in decreased expression of PPM1K mRNA CTD PMID:22334560 NCBI chr 4:88,694,395...88,721,374
Ensembl chr 4:88,694,583...88,718,533
JBrowse link
G Ppp1cc protein phosphatase 1 catalytic subunit gamma increases expression ISO epoxiconazole results in increased expression of PPP1CC mRNA CTD PMID:22334560 NCBI chr12:39,864,302...39,882,030
Ensembl chr12:39,864,295...39,882,030
JBrowse link
G Ppp1r42 protein phosphatase 1, regulatory subunit 42 increases expression ISO epoxiconazole results in increased expression of PPP1R42 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:8,911,356...8,956,313
Ensembl chr 5:8,916,633...8,956,119
JBrowse link
G Prg4 proteoglycan 4 increases expression ISO epoxiconazole results in increased expression of PRG4 mRNA CTD PMID:22334560 NCBI chr13:67,672,588...67,688,902
Ensembl chr13:67,672,878...67,688,477
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA CTD PMID:25607892 NCBI chr 1:48,880,015...50,069,998 JBrowse link
G Prlr prolactin receptor decreases expression ISO epoxiconazole results in decreased expression of PRLR mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
JBrowse link
G Prpf19 pre-mRNA processing factor 19 increases expression ISO epoxiconazole results in increased expression of PRPF19 mRNA CTD PMID:22334560 NCBI chr 1:226,947,065...226,958,147
Ensembl chr 1:226,947,105...226,958,144
JBrowse link
G Psap prosaposin increases expression ISO epoxiconazole results in increased expression of PSAP mRNA CTD PMID:22334560 NCBI chr20:29,831,302...29,856,876
Ensembl chr20:29,831,314...29,856,875
JBrowse link
G Psen1 presenilin 1 increases expression ISO epoxiconazole results in increased expression of PSEN1 mRNA CTD PMID:22334560 NCBI chr 6:107,169,514...107,221,000
Ensembl chr 6:107,169,528...107,216,798
JBrowse link
G Psma5 proteasome 20S subunit alpha 5 increases expression ISO epoxiconazole results in increased expression of PSMA5 mRNA CTD PMID:22334560 NCBI chr 2:211,050,344...211,073,706
Ensembl chr 2:211,050,360...211,073,714
JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 increases expression ISO epoxiconazole results in increased expression of PSMD12 mRNA CTD PMID:22334560 NCBI chr10:95,706,808...95,725,452
Ensembl chr10:95,706,685...95,725,812
JBrowse link
G Rab3gap1 RAB3 GTPase activating protein catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of RAB3GAP1 mRNA CTD PMID:22334560 NCBI chr13:44,578,208...44,649,876
Ensembl chr13:44,615,553...44,648,620
JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor 4 increases expression ISO epoxiconazole results in increased expression of RAPGEF4 mRNA CTD PMID:22334560 NCBI chr 3:58,632,338...58,925,127
Ensembl chr 3:58,632,476...58,924,038
JBrowse link
G Rbbp8 RB binding protein 8, endonuclease increases expression ISO epoxiconazole results in increased expression of RBBP8 mRNA CTD PMID:22334560 NCBI chr18:3,134,630...3,227,702
Ensembl chr18:3,162,543...3,227,688
JBrowse link
G Rcn2 reticulocalbin 2 increases expression ISO epoxiconazole results in increased expression of RCN2 mRNA CTD PMID:22334560 NCBI chr 8:60,709,851...60,726,938
Ensembl chr 8:60,709,851...60,726,936
JBrowse link
G Reln reelin multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA CTD PMID:25607892 NCBI chr 4:9,347,533...9,774,257
Ensembl chr 4:9,347,528...9,773,670
JBrowse link
G Rgn regucalcin decreases expression ISO epoxiconazole results in decreased expression of RGN mRNA CTD PMID:22334560 NCBI chr  X:1,833,484...1,848,904
Ensembl chr  X:1,833,492...1,848,904
JBrowse link
G Rhbdd1 rhomboid domain containing 1 increases expression ISO epoxiconazole results in increased expression of RHBDD1 mRNA CTD PMID:22334560 NCBI chr 9:88,110,731...88,229,462
Ensembl chr 9:88,110,731...88,229,479
JBrowse link
G Robo1 roundabout guidance receptor 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA CTD PMID:25607892 NCBI chr11:9,079,291...10,146,302
Ensembl chr11:9,642,365...10,143,317
JBrowse link
G Rras RAS related increases expression ISO epoxiconazole results in increased expression of RRAS mRNA CTD PMID:22334560 NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 increases expression ISO epoxiconazole results in increased expression of RSAD2 mRNA CTD PMID:22334560 NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
JBrowse link
G Rxra retinoid X receptor alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA CTD PMID:25607892 NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
JBrowse link
G S100a8 S100 calcium binding protein A8 increases expression ISO epoxiconazole results in increased expression of S100A8 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G Sar1b secretion associated, Ras related GTPase 1B increases expression ISO epoxiconazole results in increased expression of SAR1B mRNA CTD PMID:22334560 NCBI chr10:37,215,989...37,245,603
Ensembl chr10:37,215,937...37,245,658
JBrowse link
G Scap SREBF chaperone decreases expression ISO epoxiconazole results in decreased expression of SCAP mRNA CTD PMID:22334560 NCBI chr 8:118,551,869...118,628,650
Ensembl chr 8:118,570,503...118,628,651
JBrowse link
G Sec22b SEC22 homolog B, vesicle trafficking protein increases expression ISO epoxiconazole results in increased expression of SEC22B mRNA CTD PMID:22334560 NCBI chr 2:200,076,079...200,096,861
Ensembl chr 2:200,076,054...200,098,076
JBrowse link
G Sec24d SEC24 homolog D, COPII coat complex component increases expression ISO epoxiconazole results in increased expression of SEC24D mRNA CTD PMID:22334560 NCBI chr 2:227,455,704...227,562,801
Ensembl chr 2:227,455,722...227,562,319
JBrowse link
G Sec61a1 SEC61 translocon subunit alpha 1 increases expression ISO epoxiconazole results in increased expression of SEC61A1 mRNA CTD PMID:22334560 NCBI chr 4:120,453,577...120,467,932
Ensembl chr 4:120,453,581...120,467,932
JBrowse link
G Sec61b SEC61 translocon subunit beta increases expression ISO epoxiconazole results in increased expression of SEC61B mRNA CTD PMID:22334560 NCBI chr 5:63,192,322...63,200,532
Ensembl chr 5:63,192,298...63,200,508
JBrowse link
G Selenos selenoprotein S increases expression ISO epoxiconazole results in increased expression of SELENOS mRNA CTD PMID:22334560 NCBI chr 1:126,979,579...126,989,344
Ensembl chr 1:126,979,575...126,989,344
JBrowse link
G Serpina6 serpin family A member 6 increases expression ISO epoxiconazole results in increased expression of SERPINA6 mRNA CTD PMID:22334560 NCBI chr 6:127,523,948...127,534,178
Ensembl chr 6:127,523,906...127,534,247
JBrowse link
G Serpina9 serpin family A member 9 decreases expression ISO epoxiconazole results in decreased expression of SERPINA9 mRNA CTD PMID:22334560 NCBI chr 6:127,662,348...127,680,232
Ensembl chr 6:127,662,813...127,679,951
JBrowse link
G Sf3b2 splicing factor 3b, subunit 2 decreases expression ISO epoxiconazole results in decreased expression of SF3B2 mRNA CTD PMID:22334560 NCBI chr 1:220,645,685...220,665,611
Ensembl chr 1:220,645,672...220,665,603
JBrowse link
G Sgpl1 sphingosine-1-phosphate lyase 1 increases expression ISO epoxiconazole results in increased expression of SGPL1 mRNA CTD PMID:22334560 NCBI chr20:30,699,936...30,769,178
Ensembl chr20:30,699,872...30,749,940
JBrowse link
G Shank2 SH3 and multiple ankyrin repeat domains 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA CTD PMID:25607892 NCBI chr 1:217,149,156...217,593,950
Ensembl chr 1:217,151,166...217,592,763
JBrowse link
G Siae sialic acid acetylesterase increases expression ISO epoxiconazole results in increased expression of SIAE mRNA CTD PMID:22334560 NCBI chr 8:40,078,269...40,113,514
Ensembl chr 8:40,078,269...40,113,514
JBrowse link
G Sirpa signal-regulatory protein alpha increases expression ISO epoxiconazole results in increased expression of SIRPA mRNA CTD PMID:22334560 NCBI chr 3:122,113,735...122,152,478
Ensembl chr 3:122,114,108...122,152,477
JBrowse link
G Slc10a1 solute carrier family 10 member 1 increases expression ISO epoxiconazole results in increased expression of SLC10A1 mRNA CTD PMID:22334560 NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
JBrowse link
G Slc13a3 solute carrier family 13 member 3 increases expression ISO epoxiconazole results in increased expression of SLC13A3 mRNA CTD PMID:22334560 NCBI chr 3:162,084,336...162,147,398
Ensembl chr 3:162,084,315...162,147,393
JBrowse link
G Slc16a12 solute carrier family 16, member 12 increases expression ISO epoxiconazole results in increased expression of SLC16A12 mRNA CTD PMID:22334560 NCBI chr 1:252,976,071...253,054,500
Ensembl chr 1:252,976,644...253,000,760
JBrowse link
G Slc1a2 solute carrier family 1 member 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 NCBI chr 3:92,518,679...92,665,731
Ensembl chr 3:92,640,752...92,665,644
JBrowse link
G Slc1a6 solute carrier family 1 member 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA CTD PMID:25607892 NCBI chr 7:13,730,101...13,758,170
Ensembl chr 7:13,730,253...13,751,271
JBrowse link
G Slc23a1 solute carrier family 23 member 1 increases expression ISO epoxiconazole results in increased expression of SLC23A1 mRNA CTD PMID:22334560 NCBI chr18:28,413,910...28,428,133
Ensembl chr18:28,414,009...28,428,117
JBrowse link
G Slc23a2 solute carrier family 23 member 2 increases expression ISO epoxiconazole results in increased expression of SLC23A2 mRNA CTD PMID:22334560 NCBI chr 3:124,632,491...124,842,225
Ensembl chr 3:124,632,492...124,724,252
JBrowse link
G Slc25a15 solute carrier family 25 member 15 decreases expression ISO epoxiconazole results in decreased expression of SLC25A15 mRNA CTD PMID:22334560 NCBI chr16:74,505,318...74,554,523
Ensembl chr16:74,531,564...74,554,529
JBrowse link
G Slc25a22 solute carrier family 25 member 22 decreases expression ISO epoxiconazole results in decreased expression of SLC25A22 mRNA CTD PMID:22334560 NCBI chr 1:214,410,388...214,418,236
Ensembl chr 1:214,410,417...214,414,897
Ensembl chr 1:214,410,417...214,414,897
JBrowse link
G Slc25a37 solute carrier family 25 member 37 increases expression ISO epoxiconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 NCBI chr15:51,125,764...51,168,384
Ensembl chr15:51,128,268...51,168,384
JBrowse link
G Slc39a11 solute carrier family 39, member 11 increases expression ISO epoxiconazole results in increased expression of SLC39A11 mRNA CTD PMID:22334560 NCBI chr10:101,754,842...102,169,100
Ensembl chr10:101,754,830...102,084,035
JBrowse link
G Slc48a1 solute carrier family 48 member 1 increases expression ISO epoxiconazole results in increased expression of SLC48A1 mRNA CTD PMID:22334560 NCBI chr 7:139,271,698...139,279,499
Ensembl chr 7:139,271,698...139,279,499
JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 increases expression ISO epoxiconazole results in increased expression of SLCO1A4 mRNA CTD PMID:22334560 NCBI chr 4:175,969,549...176,026,227
Ensembl chr 4:175,969,549...176,026,163
JBrowse link
G Slit1 slit guidance ligand 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA CTD PMID:25607892 NCBI chr 1:260,843,481...260,992,366
Ensembl chr 1:260,843,483...260,992,366
JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 decreases expression ISO epoxiconazole results in decreased expression of SMARCA4 mRNA CTD PMID:22334560 NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468
JBrowse link
G Smpd3 sphingomyelin phosphodiesterase 3 increases expression ISO epoxiconazole results in increased expression of SMPD3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr19:38,237,963...38,321,572
Ensembl chr19:38,237,965...38,321,528
JBrowse link
G Snx17 sorting nexin 17 decreases expression ISO epoxiconazole results in decreased expression of SNX17 mRNA CTD PMID:22334560 NCBI chr 6:26,541,137...26,546,650
Ensembl chr 6:26,541,138...26,546,545
JBrowse link
G Spcs2 signal peptidase complex subunit 2 increases expression ISO epoxiconazole results in increased expression of SPCS2 mRNA CTD PMID:22334560 NCBI chr 1:164,829,896...164,849,749
Ensembl chr 1:164,829,896...164,849,749
JBrowse link
G Sptbn2 spectrin, beta, non-erythrocytic 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA CTD PMID:25607892 NCBI chr 1:219,964,429...220,006,811
Ensembl chr 1:219,964,429...220,005,068
JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 increases expression ISO epoxiconazole results in increased expression of SRD5A1 mRNA CTD PMID:22334560 NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
JBrowse link
G Srpra SRP receptor subunit alpha increases expression ISO epoxiconazole results in increased expression of SRPRA mRNA CTD PMID:22334560 NCBI chr 8:36,410,683...36,416,766
Ensembl chr 8:36,410,683...36,416,296
JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO epoxiconazole results in increased expression of SRXN1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 3:147,608,850...147,614,410
Ensembl chr 3:147,609,095...147,632,801
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of STAR mRNA CTD PMID:28454766 NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
JBrowse link
G Stat5b signal transducer and activator of transcription 5B decreases activity ISO epoxiconazole results in decreased activity of STAT5B protein CTD PMID:30114225 NCBI chr10:88,686,207...88,712,313
Ensembl chr10:88,686,207...88,754,829
JBrowse link
G Stbd1 starch binding domain 1 increases expression ISO
EXP
epoxiconazole results in increased expression of STBD1 mRNA CTD PMID:22334560 PMID:29038839 NCBI chr14:16,976,355...16,979,760
Ensembl chr14:16,976,356...16,979,760
JBrowse link
G Stmn2 stathmin 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA CTD PMID:25607892 NCBI chr 2:95,424,251...95,471,900
Ensembl chr 2:95,424,251...95,472,115
JBrowse link
G Sts steroid sulfatase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA CTD PMID:25607892 NCBI chr  X:45,420,418...45,428,748
Ensembl chr  X:45,420,596...45,428,750
JBrowse link
G Stt3a STT3 oligosaccharyltransferase complex catalytic subunit A increases expression ISO epoxiconazole results in increased expression of STT3A mRNA CTD PMID:22334560 NCBI chr 8:39,204,218...39,243,751
Ensembl chr 8:39,181,163...39,243,882
JBrowse link
G Stxbp1 syntaxin binding protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA CTD PMID:25607892 NCBI chr 3:11,823,779...11,885,479
Ensembl chr 3:11,823,785...11,885,417
JBrowse link
G Syngap1 synaptic Ras GTPase activating protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA CTD PMID:25607892 NCBI chr20:5,535,434...5,564,657
Ensembl chr20:5,535,432...5,564,437
JBrowse link
G Syp synaptophysin multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA CTD PMID:25607892 NCBI chr  X:15,694,699...15,709,244
Ensembl chr  X:15,695,566...15,707,436
JBrowse link
G Tgfa transforming growth factor alpha increases expression ISO epoxiconazole results in increased expression of TGFA mRNA CTD PMID:22334560 NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA CTD PMID:25607892 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression ISO epoxiconazole results in increased expression of TGFBR2 mRNA CTD PMID:22334560 NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
JBrowse link
G Thoc2 THO complex 2 decreases expression ISO epoxiconazole results in decreased expression of THOC2 mRNA CTD PMID:22334560 NCBI chr  X:128,153,824...128,268,327
Ensembl chr  X:128,161,895...128,268,322
JBrowse link
G Timm10b translocase of inner mitochondrial membrane 10B multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of TIMM10B mRNA CTD PMID:29038839 NCBI chr 1:170,471,265...170,474,111
Ensembl chr 1:170,471,238...170,474,113
JBrowse link
G Tlr2 toll-like receptor 2 increases expression ISO epoxiconazole results in increased expression of TLR2 mRNA CTD PMID:22334560 NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
JBrowse link
G Tm9sf4 transmembrane 9 superfamily member 4 increases expression ISO epoxiconazole results in increased expression of TM9SF4 mRNA CTD PMID:22334560 NCBI chr 3:148,635,822...148,689,961
Ensembl chr 3:148,635,775...148,688,553
JBrowse link
G Tmbim4 transmembrane BAX inhibitor motif containing 4 increases expression ISO epoxiconazole results in increased expression of TMBIM4 mRNA CTD PMID:22334560 NCBI chr 7:64,987,859...65,002,447
Ensembl chr 7:64,987,859...65,002,455
JBrowse link
G Tmed10 transmembrane p24 trafficking protein 10 increases expression ISO epoxiconazole results in increased expression of TMED10 mRNA CTD PMID:22334560 NCBI chr 6:109,169,739...109,205,004
Ensembl chr 6:109,169,741...109,205,004
JBrowse link
G Tmed3 transmembrane p24 trafficking protein 3 increases expression ISO epoxiconazole results in increased expression of TMED3 mRNA CTD PMID:22334560 NCBI chr 8:97,075,194...97,083,107
Ensembl chr 8:97,075,160...97,083,120
JBrowse link
G Tmem109 transmembrane protein 109 increases expression ISO epoxiconazole results in increased expression of TMEM109 mRNA CTD PMID:22334560 NCBI chr 1:226,925,114...226,935,710
Ensembl chr 1:226,925,117...226,935,689
JBrowse link
G Tmem167a transmembrane protein 167A increases expression ISO epoxiconazole results in increased expression of TMEM167 mRNA CTD PMID:22334560 NCBI chr 2:18,927,544...18,946,110
Ensembl chr 2:18,937,458...18,943,561
JBrowse link
G Tmem176a transmembrane protein 176A increases expression ISO epoxiconazole results in increased expression of TMEM176A mRNA CTD PMID:22334560 NCBI chr 4:78,458,735...78,462,415
Ensembl chr 4:78,458,625...78,462,423
JBrowse link
G Tmem176b transmembrane protein 176B increases expression ISO epoxiconazole results in increased expression of TMEM176B mRNA CTD PMID:22334560 NCBI chr 4:78,450,724...78,458,600
Ensembl chr 4:78,450,724...78,458,179
JBrowse link
G Tmem43 transmembrane protein 43 increases expression ISO epoxiconazole results in increased expression of TMEM43 mRNA CTD PMID:22334560 NCBI chr 4:123,118,468...123,133,610
Ensembl chr 4:123,118,468...123,133,609
JBrowse link
G Tmx2 thioredoxin-related transmembrane protein 2 increases expression ISO epoxiconazole results in increased expression of TMX2 mRNA CTD PMID:22334560 NCBI chr 3:72,073,429...72,081,079
Ensembl chr 3:72,073,431...72,081,079
JBrowse link
G Tnfrsf19 TNF receptor superfamily member 19 increases expression ISO epoxiconazole results in increased expression of TNFRSF19 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:41,249,820...41,316,203
Ensembl chr15:41,246,308...41,338,284
JBrowse link
G Tnks2 tankyrase 2 decreases expression ISO epoxiconazole results in decreased expression of TNKS2 mRNA CTD PMID:22334560 NCBI chr 1:255,478,794...255,532,143
Ensembl chr 1:255,479,261...255,532,143
JBrowse link
G Tor1b torsin family 1, member B increases expression ISO epoxiconazole results in increased expression of TOR1B mRNA CTD PMID:22334560 NCBI chr 3:9,792,818...9,798,924
Ensembl chr 3:9,792,899...9,798,923
JBrowse link
G Tsc2 TSC complex subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA CTD PMID:25607892 NCBI chr10:13,962,006...13,996,684
Ensembl chr10:13,961,947...13,996,584
JBrowse link
G Ttc39c tetratricopeptide repeat domain 39C decreases expression ISO epoxiconazole results in decreased expression of TTC39C mRNA CTD PMID:22334560 NCBI chr18:3,958,424...4,080,028
Ensembl chr18:3,958,432...4,080,025
JBrowse link
G Txn1 thioredoxin 1 increases expression ISO epoxiconazole results in increased expression of TXN1 mRNA CTD PMID:22334560 NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
JBrowse link
G Txndc17 thioredoxin domain containing 17 increases expression ISO epoxiconazole results in increased expression of TXNDC17 mRNA CTD PMID:22334560 NCBI chr10:58,776,792...58,779,764
Ensembl chr10:58,776,792...58,779,764
JBrowse link
G Uba5 ubiquitin-like modifier activating enzyme 5 increases expression ISO epoxiconazole results in increased expression of UBA5 mRNA CTD PMID:22334560 NCBI chr 8:112,578,607...112,594,192
Ensembl chr 8:112,578,590...112,594,261
JBrowse link
G Ubb ubiquitin B increases expression ISO epoxiconazole results in increased expression of UBB mRNA CTD PMID:22334560 NCBI chr10:48,880,231...48,881,896
Ensembl chr10:48,881,049...48,881,881
JBrowse link
G Ubn1 ubinuclein 1 decreases expression ISO epoxiconazole results in decreased expression of UBN1 mRNA CTD PMID:22334560 NCBI chr10:10,690,224...10,725,655
Ensembl chr10:10,690,224...10,725,655
JBrowse link
G Ubqln2 ubiquilin 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UBQLN2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UBQLN2 mRNA CTD PMID:29038839 NCBI chr  X:18,723,313...18,726,732
Ensembl chr  X:18,723,341...18,726,732
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of UGT1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UGT1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT1A1 mRNA
CTD PMID:29038839 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 increases expression ISO epoxiconazole results in increased expression of UGT1A9 mRNA CTD PMID:22334560 NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA
epoxiconazole results in increased expression of UGT2B1 mRNA
CTD PMID:29038839 NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases expression ISO epoxiconazole results in increased expression of UGT2B34 mRNA CTD PMID:22334560 NCBI chr14:22,597,103...22,619,968 JBrowse link
G Unc5b unc-5 netrin receptor B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA CTD PMID:25607892 NCBI chr20:30,339,680...30,406,593
Ensembl chr20:30,339,673...30,406,295
JBrowse link
G Vps29 VPS29 retromer complex component increases expression ISO epoxiconazole results in increased expression of VPS29 mRNA CTD PMID:22334560 NCBI chr12:39,690,069...39,699,114
Ensembl chr12:39,690,069...39,699,113
JBrowse link
G Vti1b vesicle transport through interaction with t-SNAREs 1B increases expression ISO epoxiconazole results in increased expression of VTI1B mRNA CTD PMID:22334560 NCBI chr 6:102,340,261...102,353,612
Ensembl chr 6:102,339,857...102,353,403
JBrowse link
G Vtn vitronectin decreases expression ISO epoxiconazole results in decreased expression of VTN mRNA CTD PMID:22334560 NCBI chr10:65,767,960...65,771,040
Ensembl chr10:65,767,053...65,771,038
JBrowse link
G Wdr18 WD repeat domain 18 increases expression ISO epoxiconazole results in increased expression of WDR18 mRNA CTD PMID:22334560 NCBI chr 7:12,561,318...12,569,120
Ensembl chr 7:12,561,324...12,569,143
JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases expression ISO epoxiconazole results in decreased expression of XIAP mRNA CTD PMID:22334560 NCBI chr  X:128,409,425...128,455,786
Ensembl chr  X:128,409,472...128,453,000
JBrowse link
G Xrcc1 X-ray repair cross complementing 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of XRCC1 mRNA CTD PMID:29038839 NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
JBrowse link
G Xrcc5 X-ray repair cross complementing 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 NCBI chr 9:79,659,275...79,748,050
Ensembl chr 9:79,659,251...79,748,078
JBrowse link
G Yipf5 Yip1 domain family, member 5 increases expression ISO epoxiconazole results in increased expression of YIPF5 mRNA CTD PMID:22334560 NCBI chr18:33,401,103...33,436,885
Ensembl chr18:33,401,106...33,434,775
JBrowse link
flufenacet term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO FOE 5043 results in increased activity of NFE2L2 protein CTD PMID:20143881 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
affects activity
ISO FOE 5043 results in increased activity of NR1I2 protein
FOE 5043 affects the activity of NR1I2 protein
CTD PMID:20143881 PMID:23611293 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
G Tspo translocator protein affects activity EXP FOE 5043 affects the activity of TSPO protein CTD PMID:23611293 NCBI chr 7:124,460,358...124,470,610
Ensembl chr 7:124,460,358...124,470,609
JBrowse link
flunitrazepam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity ISO Flunitrazepam results in decreased activity of AKR1C4 protein CTD PMID:11995921 NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity ISO Flunitrazepam results in decreased activity of AKR1C2 protein CTD PMID:11995921 NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Flunitrazepam results in decreased activity of AKR1C3 protein CTD PMID:11995921 NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
JBrowse link
G Casp3 caspase 3 multiple interactions ISO CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP3 protein] CTD PMID:19005028 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp7 caspase 7 multiple interactions ISO CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP7 protein] CTD PMID:19005028 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Crp C-reactive protein multiple interactions ISO [bromperidol co-treated with Flunitrazepam] results in increased expression of CRP protein CTD PMID:15298663 NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases metabolic processing ISO CYP2C19 protein results in increased metabolism of Flunitrazepam CTD PMID:10911933 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions
increases hydroxylation
ISO CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP3 protein]; CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP7 protein]; CYP3A4 protein results in increased metabolism of and results in increased activity of Flunitrazepam; Flunitrazepam promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]
CYP3A4 protein results in increased hydroxylation of Flunitrazepam
CTD PMID:15383492 PMID:19005028 PMID:19299527 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases hydroxylation ISO CYP3A5 protein results in increased hydroxylation of Flunitrazepam CTD PMID:15383492 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
JBrowse link
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 multiple interactions
affects binding
ISO
EXP
2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol promotes the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Flunitrazepam binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]
Flunitrazepam binds to GABRA1 protein
alphaxalone promotes the reaction [Flunitrazepam binds to GABRA1 protein]; Pentobarbital promotes the reaction [Flunitrazepam binds to GABRA1 protein]
CTD PMID:8397295 PMID:8632757 PMID:22029276 NCBI chr10:27,310,718...27,371,802
Ensembl chr10:27,310,725...27,366,665
JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 affects binding
multiple interactions
EXP Flunitrazepam binds to GABRA2 protein
alphaxalone promotes the reaction [Flunitrazepam binds to GABRA2 protein]; Pentobarbital promotes the reaction [Flunitrazepam binds to GABRA2 protein]
CTD PMID:8397295 NCBI chr14:39,662,411...39,801,082
Ensembl chr14:39,661,968...39,798,302
JBrowse link
G Gabrb3 gamma-aminobutyric acid type A receptor subunit beta 3 multiple interactions
affects binding
ISO 2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol promotes the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Flunitrazepam binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]] CTD PMID:8632757 PMID:22029276 NCBI chr 1:113,034,251...113,265,364
Ensembl chr 1:112,976,770...113,265,364
JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 multiple interactions
affects binding
ISO 2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol promotes the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Flunitrazepam binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]] CTD PMID:8632757 PMID:22029276 NCBI chr10:27,090,913...27,179,786
Ensembl chr10:27,092,827...27,179,900
JBrowse link
G Sstr3 somatostatin receptor 3 affects expression EXP Flunitrazepam affects the expression of SSTR3 mRNA CTD PMID:16162846 NCBI chr 7:119,760,881...119,768,082
Ensembl chr 7:119,760,888...119,768,082
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 decreases activity ISO Flunitrazepam results in decreased activity of UGT1A1 protein CTD PMID:15334623 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 decreases activity ISO Flunitrazepam results in decreased activity of UGT1A3 protein CTD PMID:15334623 NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
flurazepam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 affects response to substance ISO GABRA1 protein affects the susceptibility to Flurazepam CTD PMID:12490572 NCBI chr10:27,310,718...27,371,802
Ensembl chr10:27,310,725...27,366,665
JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 affects response to substance ISO GABRB2 protein affects the susceptibility to Flurazepam CTD PMID:12490572 NCBI chr10:27,973,694...28,193,072
Ensembl chr10:27,973,681...28,187,565
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Flurazepam results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
JBrowse link
G Trh thyrotropin releasing hormone multiple interactions EXP Flurazepam inhibits the reaction [TRH protein modified form binds to TRHR protein] CTD PMID:2845442 NCBI chr 4:124,110,716...124,113,242
Ensembl chr 4:124,110,716...124,113,242
JBrowse link
G Trhr thyrotropin releasing hormone receptor multiple interactions EXP Flurazepam inhibits the reaction [TRH protein modified form binds to TRHR protein] CTD PMID:2845442 NCBI chr 7:83,113,641...83,153,520
Ensembl chr 7:83,113,672...83,153,519
JBrowse link
flusilazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aacs acetoacetyl-CoA synthetase increases expression EXP flusilazole results in increased expression of AACS mRNA CTD PMID:28263823 NCBI chr12:36,512,393...36,555,694
Ensembl chr12:36,512,393...36,555,694
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression EXP flusilazole results in decreased expression of ABCA1 mRNA CTD PMID:22664269 PMID:28263823 NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression EXP flusilazole results in decreased expression of ABCG1 mRNA CTD PMID:22664269 NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
JBrowse link
G Abra actin-binding Rho activating protein decreases expression EXP flusilazole results in decreased expression of ABRA mRNA CTD PMID:22664269 NCBI chr 7:80,792,615...80,796,683
Ensembl chr 7:80,792,600...80,796,670
JBrowse link
G Add3 adducin 3 increases expression EXP flusilazole results in increased expression of ADD3 mRNA CTD PMID:28263823 NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
JBrowse link
G Adgrl2 adhesion G protein-coupled receptor L2 affects expression ISO flusilazole affects the expression of ADGRL2 mRNA CTD PMID:21195148 NCBI chr 2:258,792,838...258,997,145
Ensembl chr 2:258,792,839...258,997,145
JBrowse link
G Alx1 ALX homeobox 1 increases expression EXP flusilazole results in increased expression of ALX1 mRNA CTD PMID:28263823 NCBI chr 7:44,751,865...44,771,458
Ensembl chr 7:44,751,873...44,771,458
JBrowse link
G Ankrd10 ankyrin repeat domain 10 affects expression ISO flusilazole affects the expression of ANKRD10 mRNA CTD PMID:21195148 NCBI chr16:83,205,898...83,229,147
Ensembl chr16:83,206,004...83,228,194
JBrowse link
G Anxa10 annexin A10 increases expression ISO flusilazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465
JBrowse link
G Apoe apolipoprotein E affects expression ISO flusilazole affects the expression of APOE mRNA CTD PMID:22634333 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G Arg1 arginase 1 increases expression
decreases expression
EXP
ISO
flusilazole results in increased expression of ARG1 mRNA
flusilazole results in decreased expression of ARG1 mRNA
CTD PMID:22664269 PMID:32194361 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression EXP flusilazole results in decreased expression of ARRDC4 mRNA CTD PMID:28263823 NCBI chr 1:129,766,097...129,780,076
Ensembl chr 1:129,766,100...129,780,356
JBrowse link
G Asf1b anti-silencing function 1B histone chaperone affects expression ISO flusilazole affects the expression of ASF1B mRNA CTD PMID:21195148 NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
JBrowse link
G Axin2 axin 2 affects expression ISO flusilazole affects the expression of AXIN2 mRNA CTD PMID:22634333 NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
JBrowse link
G B3gnt7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 affects expression ISO flusilazole affects the expression of B3GNT7 mRNA CTD PMID:21195148 NCBI chr 9:93,326,283...93,330,234
Ensembl chr 9:93,326,283...93,330,233
JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 increases expression EXP flusilazole results in increased expression of B4GALT5 mRNA CTD PMID:28263823 NCBI chr 3:164,039,731...164,055,561
Ensembl chr 3:164,039,731...164,095,878
JBrowse link
G Begain brain-enriched guanylate kinase-associated decreases expression EXP flusilazole results in decreased expression of BEGAIN mRNA CTD PMID:28263823 NCBI chr 6:132,936,964...132,972,569
Ensembl chr 6:132,936,970...132,972,511
JBrowse link
G Bloc1s3 biogenesis of lysosomal organelles complex-1, subunit 3 affects expression ISO flusilazole affects the expression of BLOC1S3 mRNA CTD PMID:21195148 NCBI chr 1:80,414,766...80,417,385
Ensembl chr 1:80,415,686...80,416,273
JBrowse link
G Bsnd barttin CLCNK type accessory subunit beta decreases expression